Form N-CSR T. Rowe Price Capital For: Dec 31

February 23, 2026 11:07 AM UTC
0000793347falseN-CSRT. ROWE PRICE CAPITAL APPRECIATION FUND, INC.N-1A2025-12-310000793347trp:C000005427Member2025-01-012025-12-3100007933472025-01-012025-12-310000793347trp:C000005427Member2015-12-312015-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2015-12-312015-12-310000793347trp:SP500Index41343AdditionalIndexMember2015-12-312015-12-310000793347trp:C000005427Member2016-01-012016-03-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012016-03-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012016-03-310000793347trp:C000005427Member2016-01-012016-06-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012016-06-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012016-06-300000793347trp:C000005427Member2016-01-012016-09-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012016-09-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012016-09-300000793347trp:C000005427Member2016-01-012016-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012016-12-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012016-12-310000793347trp:C000005427Member2016-01-012017-03-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012017-03-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012017-03-310000793347trp:C000005427Member2016-01-012017-06-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012017-06-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012017-06-300000793347trp:C000005427Member2016-01-012017-09-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012017-09-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012017-09-300000793347trp:C000005427Member2016-01-012017-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012017-12-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012017-12-310000793347trp:C000005427Member2016-01-012018-03-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012018-03-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012018-03-310000793347trp:C000005427Member2016-01-012018-06-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012018-06-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012018-06-300000793347trp:C000005427Member2016-01-012018-09-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012018-09-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012018-09-300000793347trp:C000005427Member2016-01-012018-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012018-12-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012018-12-310000793347trp:C000005427Member2016-01-012019-03-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012019-03-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012019-03-310000793347trp:C000005427Member2016-01-012019-06-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012019-06-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012019-06-300000793347trp:C000005427Member2016-01-012019-09-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012019-09-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012019-09-300000793347trp:C000005427Member2016-01-012019-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012019-12-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012019-12-310000793347trp:C000005427Member2016-01-012020-03-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012020-03-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012020-03-310000793347trp:C000005427Member2016-01-012020-06-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012020-06-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012020-06-300000793347trp:C000005427Member2016-01-012020-09-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012020-09-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012020-09-300000793347trp:C000005427Member2016-01-012020-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012020-12-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012020-12-310000793347trp:C000005427Member2016-01-012021-03-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012021-03-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012021-03-310000793347trp:C000005427Member2016-01-012021-06-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012021-06-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012021-06-300000793347trp:C000005427Member2016-01-012021-09-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012021-09-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012021-09-300000793347trp:C000005427Member2016-01-012021-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012021-12-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012021-12-310000793347trp:C000005427Member2016-01-012022-03-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012022-03-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012022-03-310000793347trp:C000005427Member2016-01-012022-06-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012022-06-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012022-06-300000793347trp:C000005427Member2016-01-012022-09-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012022-09-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012022-09-300000793347trp:C000005427Member2016-01-012022-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012022-12-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012022-12-310000793347trp:C000005427Member2016-01-012023-03-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012023-03-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012023-03-310000793347trp:C000005427Member2016-01-012023-06-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012023-06-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012023-06-300000793347trp:C000005427Member2016-01-012023-09-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012023-09-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012023-09-300000793347trp:C000005427Member2016-01-012023-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012023-12-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012023-12-310000793347trp:C000005427Member2016-01-012024-03-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012024-03-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012024-03-310000793347trp:C000005427Member2016-01-012024-06-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012024-06-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012024-06-300000793347trp:C000005427Member2016-01-012024-09-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012024-09-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012024-09-300000793347trp:C000005427Member2016-01-012024-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012024-12-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012024-12-310000793347trp:C000005427Member2016-01-012025-03-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012025-03-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012025-03-310000793347trp:C000005427Member2016-01-012025-06-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012025-06-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012025-06-300000793347trp:C000005427Member2016-01-012025-09-300000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012025-09-300000793347trp:SP500Index41343AdditionalIndexMember2016-01-012025-09-300000793347trp:C000005427Member2016-01-012025-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2016-01-012025-12-310000793347trp:SP500Index41343AdditionalIndexMember2016-01-012025-12-310000793347trp:C000005427Memberoef:WithoutSalesLoadMember2025-01-012025-12-310000793347trp:C000005427Memberoef:WithoutSalesLoadMember2021-01-012025-12-310000793347trp:C000005427Memberoef:WithoutSalesLoadMember2016-01-012025-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2025-01-012025-12-310000793347trp:Russell3000Index41343BroadBasedIndexMember2021-01-012025-12-310000793347trp:SP500Index41343AdditionalIndexMember2025-01-012025-12-310000793347trp:SP500Index41343AdditionalIndexMember2021-01-012025-12-310000793347trp:C000005427Member2025-12-310000793347trp:C000005427Membertrp:CommonStocksCTIMember2025-12-310000793347trp:C000005427Membertrp:CorporateBondsCTIMember2025-12-310000793347trp:C000005427Membertrp:OtherHoldingsGroupingCTIMember2025-12-310000793347trp:C000005427Membertrp:USTreasuryNotesCTIMember2025-12-310000793347trp:C000005427Membertrp:MicrosoftCTIMember2025-12-310000793347trp:C000005427Membertrp:NVIDIACTIMember2025-12-310000793347trp:C000005427Membertrp:AppleCTIMember2025-12-310000793347trp:C000005427Membertrp:AlphabetCTIMember2025-12-310000793347trp:C000005427Membertrp:AmazoncomCTIMember2025-12-310000793347trp:C000005427Membertrp:HUBInternationalCTIMember2025-12-310000793347trp:C000005427Membertrp:BectonDickinsonCompanyCTIMember2025-12-310000793347trp:C000005427Membertrp:NiSourceCTIMember2025-12-310000793347trp:C000005427Membertrp:CenterPointEnergyCTIMember2025-12-310000793347trp:C000005428Member2025-01-012025-12-310000793347trp:C000005428Member2015-12-312015-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2015-12-312015-12-310000793347trp:SP500Index41344AdditionalIndexMember2015-12-312015-12-310000793347trp:C000005428Member2016-01-012016-03-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012016-03-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012016-03-310000793347trp:C000005428Member2016-01-012016-06-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012016-06-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012016-06-300000793347trp:C000005428Member2016-01-012016-09-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012016-09-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012016-09-300000793347trp:C000005428Member2016-01-012016-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012016-12-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012016-12-310000793347trp:C000005428Member2016-01-012017-03-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012017-03-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012017-03-310000793347trp:C000005428Member2016-01-012017-06-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012017-06-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012017-06-300000793347trp:C000005428Member2016-01-012017-09-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012017-09-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012017-09-300000793347trp:C000005428Member2016-01-012017-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012017-12-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012017-12-310000793347trp:C000005428Member2016-01-012018-03-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012018-03-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012018-03-310000793347trp:C000005428Member2016-01-012018-06-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012018-06-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012018-06-300000793347trp:C000005428Member2016-01-012018-09-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012018-09-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012018-09-300000793347trp:C000005428Member2016-01-012018-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012018-12-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012018-12-310000793347trp:C000005428Member2016-01-012019-03-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012019-03-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012019-03-310000793347trp:C000005428Member2016-01-012019-06-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012019-06-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012019-06-300000793347trp:C000005428Member2016-01-012019-09-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012019-09-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012019-09-300000793347trp:C000005428Member2016-01-012019-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012019-12-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012019-12-310000793347trp:C000005428Member2016-01-012020-03-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012020-03-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012020-03-310000793347trp:C000005428Member2016-01-012020-06-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012020-06-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012020-06-300000793347trp:C000005428Member2016-01-012020-09-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012020-09-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012020-09-300000793347trp:C000005428Member2016-01-012020-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012020-12-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012020-12-310000793347trp:C000005428Member2016-01-012021-03-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012021-03-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012021-03-310000793347trp:C000005428Member2016-01-012021-06-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012021-06-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012021-06-300000793347trp:C000005428Member2016-01-012021-09-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012021-09-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012021-09-300000793347trp:C000005428Member2016-01-012021-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012021-12-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012021-12-310000793347trp:C000005428Member2016-01-012022-03-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012022-03-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012022-03-310000793347trp:C000005428Member2016-01-012022-06-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012022-06-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012022-06-300000793347trp:C000005428Member2016-01-012022-09-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012022-09-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012022-09-300000793347trp:C000005428Member2016-01-012022-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012022-12-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012022-12-310000793347trp:C000005428Member2016-01-012023-03-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012023-03-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012023-03-310000793347trp:C000005428Member2016-01-012023-06-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012023-06-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012023-06-300000793347trp:C000005428Member2016-01-012023-09-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012023-09-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012023-09-300000793347trp:C000005428Member2016-01-012023-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012023-12-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012023-12-310000793347trp:C000005428Member2016-01-012024-03-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012024-03-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012024-03-310000793347trp:C000005428Member2016-01-012024-06-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012024-06-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012024-06-300000793347trp:C000005428Member2016-01-012024-09-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012024-09-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012024-09-300000793347trp:C000005428Member2016-01-012024-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012024-12-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012024-12-310000793347trp:C000005428Member2016-01-012025-03-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012025-03-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012025-03-310000793347trp:C000005428Member2016-01-012025-06-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012025-06-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012025-06-300000793347trp:C000005428Member2016-01-012025-09-300000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012025-09-300000793347trp:SP500Index41344AdditionalIndexMember2016-01-012025-09-300000793347trp:C000005428Member2016-01-012025-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2016-01-012025-12-310000793347trp:SP500Index41344AdditionalIndexMember2016-01-012025-12-310000793347trp:C000005428Memberoef:WithoutSalesLoadMember2025-01-012025-12-310000793347trp:C000005428Memberoef:WithoutSalesLoadMember2021-01-012025-12-310000793347trp:C000005428Memberoef:WithoutSalesLoadMember2016-01-012025-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2025-01-012025-12-310000793347trp:Russell3000Index41344BroadBasedIndexMember2021-01-012025-12-310000793347trp:SP500Index41344AdditionalIndexMember2025-01-012025-12-310000793347trp:SP500Index41344AdditionalIndexMember2021-01-012025-12-310000793347trp:C000005428Member2025-12-310000793347trp:C000005428Membertrp:CommonStocksCTIMember2025-12-310000793347trp:C000005428Membertrp:CorporateBondsCTIMember2025-12-310000793347trp:C000005428Membertrp:OtherHoldingsGroupingCTIMember2025-12-310000793347trp:C000005428Membertrp:USTreasuryNotesCTIMember2025-12-310000793347trp:C000005428Membertrp:MicrosoftCTIMember2025-12-310000793347trp:C000005428Membertrp:NVIDIACTIMember2025-12-310000793347trp:C000005428Membertrp:AppleCTIMember2025-12-310000793347trp:C000005428Membertrp:AlphabetCTIMember2025-12-310000793347trp:C000005428Membertrp:AmazoncomCTIMember2025-12-310000793347trp:C000005428Membertrp:HUBInternationalCTIMember2025-12-310000793347trp:C000005428Membertrp:BectonDickinsonCompanyCTIMember2025-12-310000793347trp:C000005428Membertrp:NiSourceCTIMember2025-12-310000793347trp:C000005428Membertrp:CenterPointEnergyCTIMember2025-12-310000793347trp:C000166317Member2025-01-012025-12-310000793347trp:C000166317Member2015-12-312015-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2015-12-312015-12-310000793347trp:SP500Index41345AdditionalIndexMember2015-12-312015-12-310000793347trp:C000166317Member2016-01-012016-03-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012016-03-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012016-03-310000793347trp:C000166317Member2016-01-012016-06-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012016-06-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012016-06-300000793347trp:C000166317Member2016-01-012016-09-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012016-09-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012016-09-300000793347trp:C000166317Member2016-01-012016-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012016-12-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012016-12-310000793347trp:C000166317Member2016-01-012017-03-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012017-03-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012017-03-310000793347trp:C000166317Member2016-01-012017-06-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012017-06-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012017-06-300000793347trp:C000166317Member2016-01-012017-09-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012017-09-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012017-09-300000793347trp:C000166317Member2016-01-012017-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012017-12-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012017-12-310000793347trp:C000166317Member2016-01-012018-03-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012018-03-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012018-03-310000793347trp:C000166317Member2016-01-012018-06-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012018-06-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012018-06-300000793347trp:C000166317Member2016-01-012018-09-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012018-09-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012018-09-300000793347trp:C000166317Member2016-01-012018-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012018-12-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012018-12-310000793347trp:C000166317Member2016-01-012019-03-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012019-03-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012019-03-310000793347trp:C000166317Member2016-01-012019-06-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012019-06-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012019-06-300000793347trp:C000166317Member2016-01-012019-09-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012019-09-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012019-09-300000793347trp:C000166317Member2016-01-012019-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012019-12-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012019-12-310000793347trp:C000166317Member2016-01-012020-03-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012020-03-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012020-03-310000793347trp:C000166317Member2016-01-012020-06-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012020-06-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012020-06-300000793347trp:C000166317Member2016-01-012020-09-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012020-09-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012020-09-300000793347trp:C000166317Member2016-01-012020-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012020-12-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012020-12-310000793347trp:C000166317Member2016-01-012021-03-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012021-03-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012021-03-310000793347trp:C000166317Member2016-01-012021-06-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012021-06-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012021-06-300000793347trp:C000166317Member2016-01-012021-09-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012021-09-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012021-09-300000793347trp:C000166317Member2016-01-012021-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012021-12-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012021-12-310000793347trp:C000166317Member2016-01-012022-03-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012022-03-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012022-03-310000793347trp:C000166317Member2016-01-012022-06-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012022-06-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012022-06-300000793347trp:C000166317Member2016-01-012022-09-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012022-09-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012022-09-300000793347trp:C000166317Member2016-01-012022-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012022-12-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012022-12-310000793347trp:C000166317Member2016-01-012023-03-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012023-03-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012023-03-310000793347trp:C000166317Member2016-01-012023-06-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012023-06-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012023-06-300000793347trp:C000166317Member2016-01-012023-09-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012023-09-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012023-09-300000793347trp:C000166317Member2016-01-012023-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012023-12-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012023-12-310000793347trp:C000166317Member2016-01-012024-03-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012024-03-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012024-03-310000793347trp:C000166317Member2016-01-012024-06-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012024-06-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012024-06-300000793347trp:C000166317Member2016-01-012024-09-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012024-09-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012024-09-300000793347trp:C000166317Member2016-01-012024-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012024-12-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012024-12-310000793347trp:C000166317Member2016-01-012025-03-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012025-03-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012025-03-310000793347trp:C000166317Member2016-01-012025-06-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012025-06-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012025-06-300000793347trp:C000166317Member2016-01-012025-09-300000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012025-09-300000793347trp:SP500Index41345AdditionalIndexMember2016-01-012025-09-300000793347trp:C000166317Member2016-01-012025-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2016-01-012025-12-310000793347trp:SP500Index41345AdditionalIndexMember2016-01-012025-12-310000793347trp:C000166317Memberoef:WithoutSalesLoadMember2025-01-012025-12-310000793347trp:C000166317Memberoef:WithoutSalesLoadMember2021-01-012025-12-310000793347trp:C000166317Memberoef:WithoutSalesLoadMember2016-01-012025-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2025-01-012025-12-310000793347trp:Russell3000Index41345BroadBasedIndexMember2021-01-012025-12-310000793347trp:SP500Index41345AdditionalIndexMember2025-01-012025-12-310000793347trp:SP500Index41345AdditionalIndexMember2021-01-012025-12-310000793347trp:C000166317Member2025-12-310000793347trp:C000166317Membertrp:CommonStocksCTIMember2025-12-310000793347trp:C000166317Membertrp:CorporateBondsCTIMember2025-12-310000793347trp:C000166317Membertrp:OtherHoldingsGroupingCTIMember2025-12-310000793347trp:C000166317Membertrp:USTreasuryNotesCTIMember2025-12-310000793347trp:C000166317Membertrp:MicrosoftCTIMember2025-12-310000793347trp:C000166317Membertrp:NVIDIACTIMember2025-12-310000793347trp:C000166317Membertrp:AppleCTIMember2025-12-310000793347trp:C000166317Membertrp:AlphabetCTIMember2025-12-310000793347trp:C000166317Membertrp:AmazoncomCTIMember2025-12-310000793347trp:C000166317Membertrp:HUBInternationalCTIMember2025-12-310000793347trp:C000166317Membertrp:BectonDickinsonCompanyCTIMember2025-12-310000793347trp:C000166317Membertrp:NiSourceCTIMember2025-12-310000793347trp:C000166317Membertrp:CenterPointEnergyCTIMember2025-12-31iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pureutr:Dtrp:Holding

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act File Number: 811-04519

T. Rowe Price Capital Appreciation Fund, Inc.

 

(Exact name of registrant as specified in charter)

1307 Point Street, Baltimore, MD 21231

 

(Address of principal executive offices)

David Oestreicher

1307 Point Street, Baltimore, MD 21231

 

(Name and address of agent for service)

Registrant’s telephone number, including area code: (410) 345-2000

Date of fiscal year end: December 31

Date of reporting period: December 31, 2025


Item 1. Reports to Shareholders

(a) Report pursuant to Rule 30e-1

 

Image

Annual Shareholder Report

December 31, 2025

Capital Appreciation Fund

Investor Class (PRWCX)

This annual shareholder report contains important information about Capital Appreciation Fund (the "fund") for the period of January 1, 2025 to December 31, 2025. You can find the fund’s prospectus, financial information on Form N‑CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information atwww.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1‑800‑638‑5660 or [email protected] or contacting your intermediary. 

What were the fund costs for the last year? (based on a hypothetical $10,000 investment)

 
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Capital Appreciation Fund - Investor Class
$74
0.70%

What drove fund performance during the past 12 months?

  • Major U.S. stock market indexes rose in 2025. After a challenging start to the year, the market climbed the proverbial wall of worry, overcoming concerns about tariffs, the economy, conflicts in the Middle East and Ukraine, the longest federal government shutdown in U.S. history, and heightened valuations among artificial intelligence-related companies.

  • Versus the all-equity S&P 500 Index, the leading contributor to relative performance was an underweight allocation to consumer staples, as the traditionally defensive sector lagged the broader benchmark in a market that strongly favored growth-oriented names. Portfolio positioning in the industrials and business services sector also added value, due in part to a favorable overweight allocation held early in the period.

  • On the negative side, stock selection in health care was the leading detractor from relative results. Within the sector, positions in Becton, Dickinson & Company and Revvity weighed on relative results, as uncertainty surrounding research funding and the impact of tariffs and other regulatory outcomes weighed heavily on the life sciences tools and health care equipment and supplies industries. Stock selection in the information technology sector also weighed on relative results, driven by our positions in Aurora Innovations, an autonomous driving company, and Roper, a software company.

  • The fund seeks long-term capital appreciation by investing primarily in common stocks. It also holds fixed income and other securities to help preserve principal value. Notable changes in positioning during the period included adding exposure to financials and utilities and reducing exposure to industrials and business services and health care.

How has the fund performed?

Cumulative Returns of a Hypothetical $10,000 Investment as of December 31, 2025

A line chart as described in the following paragraph. 

Investor Class 29,083 
Regulatory Benchmark 38,012 
Strategy Benchmark 39,827
Investor Class
Regulatory Benchmark
Strategy Benchmark
2015
10,000
10,000
10,000
2016
10,204
10,097
10,135
2016
10,519
10,362
10,384
2016
10,806
10,818
10,784
2016
10,822
11,274
11,196
2017
11,401
11,921
11,875
2017
11,814
12,280
12,242
2017
12,128
12,842
12,790
2017
12,486
13,656
13,640
2018
12,539
13,568
13,537
2018
12,804
14,095
14,002
2018
13,409
15,099
15,081
2018
12,563
12,940
13,042
2019
14,059
14,757
14,822
2019
14,751
15,361
15,460
2019
14,836
15,540
15,723
2019
15,655
16,954
17,149
2020
13,779
13,410
13,788
2020
15,675
16,364
16,620
2020
16,597
17,871
18,105
2020
18,497
20,495
20,304
2021
19,251
21,796
21,558
2021
20,335
23,592
23,401
2021
20,682
23,568
23,537
2021
21,925
25,754
26,132
2022
21,278
24,395
24,931
2022
18,787
20,321
20,916
2022
18,300
19,413
19,895
2022
19,307
20,808
21,399
2023
20,540
22,302
23,004
2023
21,489
24,172
25,015
2023
21,183
23,386
24,196
2023
22,942
26,209
27,025
2024
24,126
28,835
29,878
2024
24,566
29,762
31,157
2024
25,919
31,616
32,992
2024
25,853
32,448
33,786
2025
25,845
30,916
32,343
2025
27,488
34,314
35,882
2025
28,593
37,120
38,797
2025
29,083
38,012
39,827

202501-4140694, 202601-5112173

F72-052 2/26

Average Annual Total Returns

 
1 Year
5 Years
10 Years
Capital Appreciation Fund (Investor Class)
12.50%
9.47%
11.27%
Russell 3000 Index (Regulatory Benchmark)
17.15
13.15
14.29
S&P 500 Index (Strategy Benchmark)
17.88
14.42
14.82

The preceding line graph shows the value of a hypothetical $10,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund’s performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). The fund's total return figures reflect the reinvestment of dividends and capital gains, if any.Neither the fund’s returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares.The fund’s past performance is not a good predictor of the fund’s future performance.Updated performance information can be found at www.troweprice.com.

What are some fund statistics?

Fund Statistics

  • Total Net Assets (000s)$70,588,736
  • Number of Portfolio Holdings224
  • Investment Advisory Fees Paid (000s)$377,165
  • Portfolio Turnover Rate124.7%

What did the fund invest in?

Security Allocation (as a % of Net Assets)

Common and Preferred Stocks
64.8%
Bonds
31.9
Reserves
3.3

Top Ten Holdings (as a % of Net Assets)

U.S. Treasury Notes
16.3%
Microsoft
4.5
NVIDIA
4.2
Apple
3.8
Alphabet
3.6
Amazon.com
3.5
HUB International
2.6
Becton Dickinson & Company
2.5
NiSource
2.1
CenterPoint Energy
2.1

If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.

Frank Russell Company "LSE" and S&P do not accept any liability for any errors or omissions in the indexes or data, and hereby expressly disclaim all warranties of originality, accuracy, completeness, timeliness, merchantability and fitness for a particular purpose. No party may rely on any indexes or data contained in this communication. Visit www.troweprice.com/en/us/market-data-disclosures for additional legal notices & disclaimers.

Capital Appreciation Fund 

Investor Class (PRWCX)

T. Rowe Price Investment Services, Inc.

1307 Point Street

Baltimore, Maryland 21231

Image
Image

Annual Shareholder Report

December 31, 2025

Capital Appreciation Fund

Advisor Class (PACLX)

This annual shareholder report contains important information about Capital Appreciation Fund (the "fund") for the period of January 1, 2025 to December 31, 2025. You can find the fund’s prospectus, financial information on Form N‑CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information atwww.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1‑800‑638‑5660 or [email protected] or contacting your intermediary. 

What were the fund costs for the last year? (based on a hypothetical $10,000 investment)

 
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Capital Appreciation Fund - Advisor Class
$103
0.97%

What drove fund performance during the past 12 months?

  • Major U.S. stock market indexes rose in 2025. After a challenging start to the year, the market climbed the proverbial wall of worry, overcoming concerns about tariffs, the economy, conflicts in the Middle East and Ukraine, the longest federal government shutdown in U.S. history, and heightened valuations among artificial intelligence-related companies.

  • Versus the all-equity S&P 500 Index, the leading contributor to relative performance was an underweight allocation to consumer staples, as the traditionally defensive sector lagged the broader benchmark in a market that strongly favored growth-oriented names. Portfolio positioning in the industrials and business services sector also added value, due in part to a favorable overweight allocation held early in the period.

  • On the negative side, stock selection in health care was the leading detractor from relative results. Within the sector, positions in Becton, Dickinson & Company and Revvity weighed on relative results, as uncertainty surrounding research funding and the impact of tariffs and other regulatory outcomes weighed heavily on the life sciences tools and health care equipment and supplies industries. Stock selection in the information technology sector also weighed on relative results, driven by our positions in Aurora Innovations, an autonomous driving company, and Roper, a software company.

  • The fund seeks long-term capital appreciation by investing primarily in common stocks. It also holds fixed income and other securities to help preserve principal value. Notable changes in positioning during the period included adding exposure to financials and utilities and reducing exposure to industrials and business services and health care.

How has the fund performed?

Cumulative Returns of a Hypothetical $10,000 Investment as of December 31, 2025

A line chart as described in the following paragraph. 

Advisor Class 28,268 
Regulatory Benchmark 38,012 
Strategy Benchmark 39,827
Advisor Class
Regulatory Benchmark
Strategy Benchmark
2015
10,000
10,000
10,000
2016
10,193
10,097
10,135
2016
10,504
10,362
10,384
2016
10,782
10,818
10,784
2016
10,790
11,274
11,196
2017
11,355
11,921
11,875
2017
11,759
12,280
12,242
2017
12,058
12,842
12,790
2017
12,406
13,656
13,640
2018
12,450
13,568
13,537
2018
12,707
14,095
14,002
2018
13,297
15,099
15,081
2018
12,453
12,940
13,042
2019
13,923
14,757
14,822
2019
14,596
15,361
15,460
2019
14,672
15,540
15,723
2019
15,467
16,954
17,149
2020
13,604
13,410
13,788
2020
15,467
16,364
16,620
2020
16,364
17,871
18,105
2020
18,220
20,495
20,304
2021
18,955
21,796
21,558
2021
20,004
23,592
23,401
2021
20,334
23,568
23,537
2021
21,539
25,754
26,132
2022
20,889
24,395
24,931
2022
18,434
20,321
20,916
2022
17,944
19,413
19,895
2022
18,916
20,808
21,399
2023
20,111
22,302
23,004
2023
21,027
24,172
25,015
2023
20,717
23,386
24,196
2023
22,419
26,209
27,025
2024
23,560
28,835
29,878
2024
23,970
29,762
31,157
2024
25,279
31,616
32,992
2024
25,202
32,448
33,786
2025
25,180
30,916
32,343
2025
26,757
34,314
35,882
2025
27,816
37,120
38,797
2025
28,268
38,012
39,827

202501-4140694, 202601-5112173

F272-052 2/26

Average Annual Total Returns

 
1 Year
5 Years
10 Years
Capital Appreciation Fund (Advisor Class)
12.16%
9.18%
10.95%
Russell 3000 Index (Regulatory Benchmark)
17.15
13.15
14.29
S&P 500 Index (Strategy Benchmark)
17.88
14.42
14.82

The preceding line graph shows the value of a hypothetical $10,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund’s performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). The fund's total return figures reflect the reinvestment of dividends and capital gains, if any.Neither the fund’s returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares.The fund’s past performance is not a good predictor of the fund’s future performance.Updated performance information can be found at www.troweprice.com.

What are some fund statistics?

Fund Statistics

  • Total Net Assets (000s)$70,588,736
  • Number of Portfolio Holdings224
  • Investment Advisory Fees Paid (000s)$377,165
  • Portfolio Turnover Rate124.7%

What did the fund invest in?

Security Allocation (as a % of Net Assets)

Common and Preferred Stocks
64.8%
Bonds
31.9
Reserves
3.3

Top Ten Holdings (as a % of Net Assets)

U.S. Treasury Notes
16.3%
Microsoft
4.5
NVIDIA
4.2
Apple
3.8
Alphabet
3.6
Amazon.com
3.5
HUB International
2.6
Becton Dickinson & Company
2.5
NiSource
2.1
CenterPoint Energy
2.1

If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.

Frank Russell Company "LSE" and S&P do not accept any liability for any errors or omissions in the indexes or data, and hereby expressly disclaim all warranties of originality, accuracy, completeness, timeliness, merchantability and fitness for a particular purpose. No party may rely on any indexes or data contained in this communication. Visit www.troweprice.com/en/us/market-data-disclosures for additional legal notices & disclaimers.

Capital Appreciation Fund 

Advisor Class (PACLX)

T. Rowe Price Investment Services, Inc.

1307 Point Street

Baltimore, Maryland 21231

Image
Image

Annual Shareholder Report

December 31, 2025

Capital Appreciation Fund

I Class (TRAIX)

This annual shareholder report contains important information about Capital Appreciation Fund (the "fund") for the period of January 1, 2025 to December 31, 2025. You can find the fund’s prospectus, financial information on Form N‑CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information atwww.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1‑800‑638‑5660 or [email protected] or contacting your intermediary. 

What were the fund costs for the last year? (based on a hypothetical $10,000 investment)

 
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Capital Appreciation Fund - I Class
$61
0.57%

What drove fund performance during the past 12 months?

  • Major U.S. stock market indexes rose in 2025. After a challenging start to the year, the market climbed the proverbial wall of worry, overcoming concerns about tariffs, the economy, conflicts in the Middle East and Ukraine, the longest federal government shutdown in U.S. history, and heightened valuations among artificial intelligence-related companies.

  • Versus the all-equity S&P 500 Index, the leading contributor to relative performance was an underweight allocation to consumer staples, as the traditionally defensive sector lagged the broader benchmark in a market that strongly favored growth-oriented names. Portfolio positioning in the industrials and business services sector also added value, due in part to a favorable overweight allocation held early in the period.

  • On the negative side, stock selection in health care was the leading detractor from relative results. Within the sector, positions in Becton, Dickinson & Company and Revvity weighed on relative results, as uncertainty surrounding research funding and the impact of tariffs and other regulatory outcomes weighed heavily on the life sciences tools and health care equipment and supplies industries. Stock selection in the information technology sector also weighed on relative results, driven by our positions in Aurora Innovations, an autonomous driving company, and Roper, a software company.

  • The fund seeks long-term capital appreciation by investing primarily in common stocks. It also holds fixed income and other securities to help preserve principal value. Notable changes in positioning during the period included adding exposure to financials and utilities and reducing exposure to industrials and business services and health care.

How has the fund performed?

Cumulative Returns of a Hypothetical $500,000 Investment as of December 31, 2025

A line chart as described in the following paragraph. 

I Class 1,470,805 
Regulatory Benchmark 1,900,583 
Strategy Benchmark 1,991,370
I Class
Regulatory Benchmark
Strategy Benchmark
2015
500,000
500,000
500,000
2016
510,176
504,841
506,739
2016
526,337
518,121
519,181
2016
540,702
540,907
539,180
2016
541,686
563,676
559,800
2017
570,826
596,049
593,758
2017
591,700
614,023
612,094
2017
607,407
642,092
639,518
2017
625,532
682,784
682,013
2018
628,406
678,383
676,835
2018
641,894
704,764
700,077
2018
672,408
754,971
754,058
2018
630,265
646,994
652,111
2019
705,517
737,854
741,111
2019
740,176
768,069
773,007
2019
744,686
776,999
786,135
2019
785,971
847,685
857,437
2020
692,128
670,521
689,397
2020
787,481
818,221
831,021
2020
834,025
893,559
905,227
2020
929,868
1,024,747
1,015,195
2021
968,000
1,089,787
1,077,883
2021
1,022,746
1,179,583
1,170,030
2021
1,040,722
1,178,384
1,176,840
2021
1,103,445
1,287,709
1,306,611
2022
1,071,228
1,219,738
1,246,526
2022
946,236
1,016,027
1,045,822
2022
922,073
970,666
994,758
2022
972,826
1,040,379
1,069,973
2023
1,035,346
1,115,082
1,150,189
2023
1,083,464
1,208,602
1,250,740
2023
1,068,407
1,169,276
1,209,798
2023
1,157,482
1,310,429
1,351,243
2024
1,217,576
1,441,725
1,493,879
2024
1,240,111
1,488,091
1,557,874
2024
1,308,740
1,580,787
1,649,579
2024
1,306,065
1,622,413
1,689,320
2025
1,306,065
1,545,804
1,617,149
2025
1,389,841
1,715,707
1,794,104
2025
1,446,068
1,855,986
1,939,867
2025
1,470,805
1,900,583
1,991,370

202501-4140694, 202601-5112173

F434-052 2/26

Average Annual Total Returns

 
1 Year
5 Years
10 Years
Capital Appreciation Fund (I Class)
12.61%
9.60%
11.39%
Russell 3000 Index (Regulatory Benchmark)
17.15
13.15
14.29
S&P 500 Index (Strategy Benchmark)
17.88
14.42
14.82

The preceding line graph shows the value of a hypothetical $500,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund’s performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). The fund's total return figures reflect the reinvestment of dividends and capital gains, if any.Neither the fund’s returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares.The fund’s past performance is not a good predictor of the fund’s future performance.Updated performance information can be found at www.troweprice.com.

What are some fund statistics?

Fund Statistics

  • Total Net Assets (000s)$70,588,736
  • Number of Portfolio Holdings224
  • Investment Advisory Fees Paid (000s)$377,165
  • Portfolio Turnover Rate124.7%

What did the fund invest in?

Security Allocation (as a % of Net Assets)

Common and Preferred Stocks
64.8%
Bonds
31.9
Reserves
3.3

Top Ten Holdings (as a % of Net Assets)

U.S. Treasury Notes
16.3%
Microsoft
4.5
NVIDIA
4.2
Apple
3.8
Alphabet
3.6
Amazon.com
3.5
HUB International
2.6
Becton Dickinson & Company
2.5
NiSource
2.1
CenterPoint Energy
2.1

If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.

Frank Russell Company "LSE" and S&P do not accept any liability for any errors or omissions in the indexes or data, and hereby expressly disclaim all warranties of originality, accuracy, completeness, timeliness, merchantability and fitness for a particular purpose. No party may rely on any indexes or data contained in this communication. Visit www.troweprice.com/en/us/market-data-disclosures for additional legal notices & disclaimers.

Capital Appreciation Fund 

I Class (TRAIX)

T. Rowe Price Investment Services, Inc.

1307 Point Street

Baltimore, Maryland 21231

Image


Item 1. (b) Notice pursuant to Rule 30e-3.

Not applicable.

Item 2. Code of Ethics.

The registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR, applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of this code of ethics is filed as an exhibit to this Form N-CSR. No substantive amendments were approved or waivers were granted to this code of ethics during the period covered by this report.

Item 3. Audit Committee Financial Expert.

The registrant’s Board of Directors has determined that Mr. Paul F. McBride qualifies as an audit committee financial expert, as defined in Item 3 of Form N-CSR. Mr. McBride is considered independent for purposes of Item 3 of Form N-CSR.

Item 4. Principal Accountant Fees and Services.

(a) – (d) Aggregate fees billed for the last two fiscal years for professional services rendered to, or on behalf of, the registrant by the registrant’s principal accountant were as follows:

 

  

  

       

2025

            

2024

      
  

Audit Fees

   $ 46,217        $ 46,029  
  

Audit-Related Fees

     -          -  
  

Tax Fees

     125          -  
  

All Other Fees

     -          -  

Audit fees include amounts related to the audit of the registrant’s annual financial statements and services normally provided by the accountant in connection with statutory and regulatory filings. Audit-related fees include amounts reasonably related to the performance of the audit of the registrant’s financial statements and specifically include the issuance of a report on internal controls and, if applicable, agreed-upon procedures related to fund acquisitions. Tax fees include amounts related to services for tax compliance, tax planning, and tax advice. The nature of these services specifically includes the review of distribution calculations and the preparation of Federal, state, and excise tax returns. All other fees include the registrant’s pro-rata share of amounts for agreed-upon procedures in conjunction with service contract approvals by the registrant’s Board of Directors/Trustees.

(e)(1) The registrant’s audit committee has adopted a policy whereby audit and non-audit services performed by the registrant’s principal accountant for the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant require pre-approval in advance at regularly scheduled audit committee meetings. If such a service is required between regularly scheduled audit committee meetings, pre-approval may be authorized by one audit committee member with ratification at the next scheduled audit committee meeting. Waiver of pre-approval for audit or non-audit services requiring fees of a de minimis amount is not permitted.

 (2) No services included in (b) – (d) above were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

 


(f) Less than 50 percent of the hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees.

(g) The aggregate fees billed for the most recent fiscal year and the preceding fiscal year by the registrant’s principal accountant for non-audit services rendered to the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant were $1,862,000 and $1,262,000, respectively.

(h) All non-audit services rendered in (g) above were pre-approved by the registrant’s audit committee. Accordingly, these services were considered by the registrant’s audit committee in maintaining the principal accountant’s independence.

(i) Not applicable.

(j) Not applicable.

Item 5. Audit Committee of Listed Registrants.

Not applicable.

Item 6. Investments.

(a) Not applicable. The complete schedule of investments is included in Item 7 of this Form N-CSR.

(b) Not applicable.

Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.

(a – b) Report pursuant to Regulation S-X.

 


Financial
Highlights
Portfolio
of
Investments
Financial
Statements
and
Notes
Additional
Fund
Information
December
31,
2025
Financial
Statements
and
Other
Information
For
more
insights
from
T.
Rowe
Price
investment
professionals,
go
to
troweprice.com
.
T.
ROWE
PRICE
PRWCX
Capital
Appreciation
Fund
PACLX
Capital
Appreciation
Fund–
.
Advisor Class
TRAIX
Capital
Appreciation
Fund–
.
I Class
T.
ROWE
PRICE
Capital
Appreciation
Fund
Financial
Highlights
2
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Investor
Class
..
Year
..
..
Ended
.
12/31/25
12/31/24
12/31/23
12/31/22
12/31/21
NET
ASSET
VALUE
Beginning
of
period
$
34
.62‌
$
33
.91‌
$
29
.73‌
$
36
.96‌
$
34
.11‌
Investment
activities
Net
investment
income
(1)(2)
0
.68‌
0
.81‌
0
.77‌
0
.49‌
0
.35‌
Net
realized
and
unrealized
gain/loss
3
.60‌
3
.49‌
4
.81‌
(
4
.91‌
)
5
.91‌
Total
from
investment
activities
4
.28‌
4
.30‌
5
.58‌
(
4
.42‌
)
6
.26‌
Distributions
Net
investment
income
(
0
.68‌
)
(
0
.80‌
)
(
0
.71‌
)
(
0
.47‌
)
(
0
.35‌
)
Net
realized
gain
(
2
.47‌
)
(
2
.79‌
)
(
0
.69‌
)
(
2
.34‌
)
(
3
.06‌
)
Total
distributions
(
3
.15‌
)
(
3
.59‌
)
(
1
.40‌
)
(
2
.81‌
)
(
3
.41‌
)
NET
ASSET
VALUE
End
of
period
$
35
.75‌
$
34
.62‌
$
33
.91‌
$
29
.73‌
$
36
.96‌
Ratios/Supplemental
Data
Total
return
(2)(3)
12
.50‌
%
12
.69‌
%
18
.83‌
%
(
11
.94‌
)
%
18
.53‌
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/payments
by
Price
Associates
0
.73‌
%
0
.72‌
%
0
.73‌
%
0
.73‌
%
0
.70‌
%
Net
expenses
after
waivers/
payments
by
Price
Associates
0
.70‌
%
0
.70‌
%
0
.70‌
%
0
.71‌
%
0
.68‌
%
Net
investment
income
1
.85‌
%
2
.23‌
%
2
.38‌
%
1
.45‌
%
0
.95‌
%
Portfolio
turnover
rate
124
.7‌
%
85
.0‌
%
65
.1‌
%
83
.9‌
%
47
.8‌
%
Net
assets,
end
of
period
(in
millions)
$37,424
$34,860
$31,624
$26,104
$40,460
0‌
%
0‌
%
0‌
%
0‌
%
0‌
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
Includes
the
impact
of
expense-related
arrangements
with
Price
Associates.
(3)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
T.
ROWE
PRICE
Capital
Appreciation
Fund
Financial
Highlights
3
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Advisor
Class
..
Year
..
..
Ended
.
12/31/25
12/31/24
12/31/23
12/31/22
12/31/21
NET
ASSET
VALUE
Beginning
of
period
$
34
.04‌
$
33
.39‌
$
29
.30‌
$
36
.49‌
$
33
.70‌
Investment
activities
Net
investment
income
(1)(2)
0
.57‌
0
.70‌
0
.68‌
0
.40‌
0
.24‌
Net
realized
and
unrealized
gain/loss
3
.53‌
3
.45‌
4
.73‌
(
4
.85‌
)
5
.84‌
Total
from
investment
activities
4
.10‌
4
.15‌
5
.41‌
(
4
.45‌
)
6
.08‌
Distributions
Net
investment
income
(
0
.59‌
)
(
0
.71‌
)
(
0
.63‌
)
(
0
.40‌
)
(
0
.23‌
)
Net
realized
gain
(
2
.47‌
)
(
2
.79‌
)
(
0
.69‌
)
(
2
.34‌
)
(
3
.06‌
)
Total
distributions
(
3
.06‌
)
(
3
.50‌
)
(
1
.32‌
)
(
2
.74‌
)
(
3
.29‌
)
NET
ASSET
VALUE
End
of
period
$
35
.08‌
$
34
.04‌
$
33
.39‌
$
29
.30‌
$
36
.49‌
Ratios/Supplemental
Data
Total
return
(2)(3)
12
.16‌
%
12
.41‌
%
18
.52‌
%
(
12
.18‌
)
%
18
.22‌
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/payments
by
Price
Associates
0
.99‌
%
0
.99‌
%
0
.99‌
%
0
.99‌
%
0
.99‌
%
Net
expenses
after
waivers/payments
by
Price
Associates
0
.97‌
%
0
.96‌
%
0
.96‌
%
0
.97‌
%
0
.97‌
%
Net
investment
income
1
.59‌
%
1
.96‌
%
2
.12‌
%
1
.22‌
%
0
.66‌
%
Portfolio
turnover
rate
124
.7‌
%
85
.0‌
%
65
.1‌
%
83
.9‌
%
47
.8‌
%
Net
assets,
end
of
period
(in
millions)
$829
$790
$759
$654
$795
0‌
%
0‌
%
0‌
%
0‌
%
0‌
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
Includes
the
impact
of
expense-related
arrangements
with
Price
Associates.
(3)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
T.
ROWE
PRICE
Capital
Appreciation
Fund
Financial
Highlights
4
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
I
Class
..
Year
..
..
Ended
.
12/31/25
12/31/24
12/31/23
12/31/22
12/31/21
NET
ASSET
VALUE
Beginning
of
period
$
34
.61‌
$
33
.90‌
$
29
.72‌
$
36
.99‌
$
34
.14‌
Investment
activities
Net
investment
income
(1)(2)
0
.72‌
0
.85‌
0
.81‌
0
.56‌
0
.40‌
Net
realized
and
unrealized
gain/loss
3
.60‌
3
.50‌
4
.82‌
(
4
.95‌
)
5
.91‌
Total
from
investment
activities
4
.32‌
4
.35‌
5
.63‌
(
4
.39‌
)
6
.31‌
Distributions
Net
investment
income
(
0
.73‌
)
(
0
.85‌
)
(
0
.76‌
)
(
0
.54‌
)
(
0
.40‌
)
Net
realized
gain
(
2
.47‌
)
(
2
.79‌
)
(
0
.69‌
)
(
2
.34‌
)
(
3
.06‌
)
Total
distributions
(
3
.20‌
)
(
3
.64‌
)
(
1
.45‌
)
(
2
.88‌
)
(
3
.46‌
)
NET
ASSET
VALUE
End
of
period
$
35
.73‌
$
34
.61‌
$
33
.90‌
$
29
.72‌
$
36
.99‌
Ratios/Supplemental
Data
Total
return
(2)(3)
12
.61‌
%
12
.84‌
%
18
.98‌
%
(
11
.84‌
)
%
18
.67‌
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/payments
by
Price
Associates
0
.60‌
%
0
.60‌
%
0
.60‌
%
0
.60‌
%
0
.59‌
%
Net
expenses
after
waivers/payments
by
Price
Associates
0
.57‌
%
0
.57‌
%
0
.58‌
%
0
.58‌
%
0
.57‌
%
Net
investment
income
1
.98‌
%
2
.35‌
%
2
.50‌
%
1
.67‌
%
1
.06‌
%
Portfolio
turnover
rate
124
.7‌
%
85
.0‌
%
65
.1‌
%
83
.9‌
%
47
.8‌
%
Net
assets,
end
of
period
(in
millions)
$32,336
$28,586
$24,084
$18,698
$12,654
0‌
%
0‌
%
0‌
%
0‌
%
0‌
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
Includes
the
impact
of
expense-related
arrangements
with
Price
Associates.
(3)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
T.
ROWE
PRICE
Capital
Appreciation
Fund
December
31,
2025
5
Portfolio
of
Investments
Shares/Par
$
Value
(Cost
and
value
in
$000s)
ASSET-BACKED
SECURITIES
 0.1%
Domino's
Pizza
Master
Issuer
Series 2017-1A,
Class
A23
4.118%,
7/25/47 (1)
22,249,988‌
22,122‌
Domino's
Pizza
Master
Issuer
Series 2019-1A,
Class
A2
3.668%,
10/25/49 (1)
17,777,472‌
17,112‌
Total
Asset-Backed
Securities
(Cost
$39,859)
39,234‌
BANK
LOANS
 8.3%
(2)
AmWINS
Group,
FRN
1M
TSFR
+
2.25%,
5.966%,
1/30/32 
379,783,857‌
380,733‌
Applied
Systems,
FRN
3M
TSFR
+
2.50%,
6.172%,
2/24/31 
865,214,055‌
869,722‌
Applied
Systems,
FRN
3M
TSFR
+
4.50%,
8.172%,
2/23/32 
121,231,360‌
123,012‌
Ascend
Learning,
FRN
1M
TSFR
+
3.00%,
6.716%,
12/11/28 
205,728,052‌
206,205‌
Bending
Spoons
U.S.,
FRN
1M
TSFR
+
5.88%,
3/7/31 (3)(4)
173,424,000‌
167,788‌
Bending
Spoons
U.S.,
FRN
1M
TSFR
+
5.88%,
9.55%,
3/7/31 
13,156,154‌
12,740‌
Broadstreet
Partners,
FRN
1M
TSFR
+
2.75%,
6.466%,
6/13/31 
415,527,225‌
416,728‌
CCC
Intelligent
Solutions,
FRN
1M
TSFR
+
2.00%,
5.716%,
1/23/32 
56,234,459‌
56,375‌
CPI
Holdco
B,
FRN
1M
TSFR
+
2.00%,
5.716%,
5/17/31 (4)
181,081,520‌
181,409‌
Ellucian
Holdings,
FRN
1M
TSFR
+
2.75%,
6.466%,
10/9/29 
147,758,550‌
148,497‌
EP
Wealth
Advisors,
FRN
3M
TSFR
+
3.00%,
6.672%,
10/18/32 
20,761,000‌
20,813‌
Epicor
Software,
FRN
1M
TSFR
+
2.50%,
6.216%,
5/30/31 
106,581,346‌
106,868‌
Filtration
Group,
FRN
1M
EURIBOR
+
3.50%,
5.401%,
10/21/28
(EUR) 
65,339,526‌
77,747‌
Filtration
Group,
FRN
1M
TSFR
+
2.75%,
6.466%,
10/21/28 
319,303,930‌
320,766‌
Hilton
Domestic
Operating,
FRN
1M
TSFR
+
1.75%,
5.477%,
11/8/30 
212,355,459‌
213,553‌
HUB
International,
FRN
3M
TSFR
+
2.25%,
6.12%,
6/20/30 
806,792,151‌
810,616‌
Icon
Parent,
FRN
3M
TSFR
+
2.75%,
6.439%,
11/13/31 
180,468,332‌
180,672‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
6
Shares/Par
$
Value
(Cost
and
value
in
$000s)
Icon
Parent,
FRN
3M
TSFR
+
5.00%,
8.841%,
11/12/32 
56,930,700‌
56,931‌
Loire
Finco
Luxembourg,
FRN
1M
TSFR
+
4.00%,
7.716%,
1/21/30 
179,844,962‌
179,575‌
Mariner
Wealth
Advisors,
FRN
3M
TSFR
+
2.25%,
5.936%,
12/30/30 (4)
103,635,456‌
104,095‌
Mister
Car
Wash
Holdings,
FRN
1M
TSFR
+
2.50%,
6.216%,
3/27/31 
29,499,634‌
29,584‌
Quartz
AcquireCo,
FRN
3M
TSFR
+
2.25%,
5.922%,
6/28/30 (3)
36,323,651‌
36,233‌
Ryan
Specialty,
FRN
1M
TSFR
+
2.00%,
5.716%,
9/15/31 
8,220,482‌
8,226‌
SBA
Senior
Finance
II,
FRN
1M
TSFR
+
1.75%,
5.47%,
1/25/31 
101,214,062‌
101,583‌
Storable,
FRN
1M
TSFR
+
3.25%,
6.966%,
4/16/31 
64,842,127‌
65,085‌
TransDigm,
FRN
1M
TSFR
+
2.25%,
5.966%,
3/22/30 
284,058,669‌
284,828‌
UKG,
FRN
3M
TSFR
+
2.50%,
6.338%,
2/10/31 
173,571,125‌
173,641‌
USI,
FRN
3M
TSFR
+
2.25%,
5.922%,
11/21/29 
166,110,255‌
166,436‌
USI,
FRN
3M
TSFR
+
2.25%,
5.922%,
9/29/30 
166,516,403‌
166,748‌
Varsity
Brands,
FRN
3M
TSFR
+
3.00%,
6.672%,
8/26/31 
173,645,083‌
174,189‌
Wyndham
Hotels
&
Resorts,
FRN
1M
TSFR
+
1.75%,
5.466%,
5/24/30 
36,412,863‌
36,476‌
Total
Bank
Loans
(Cost
$5,837,132)
5,877,874‌
BOND
FUNDS
 1.4%
T.
Rowe
Price
Institutional
Floating
Rate
Fund
-
Institutional
Class,
6.59% (5)(6)
104,135,932‌
980,961‌
Total
Bond
Funds
(Cost
$1,003,397)
980,961‌
COMMON
STOCKS
 62.5%
COMMUNICATION
SERVICES
 5.4%
Interactive
Media
&
Services
 5.4%
Alphabet,
Class
A (7)
8,423,596‌
2,636,585‌
Meta
Platforms,
Class
1,734,221‌
1,144,742‌
Total
Communication
Services
3,781,327‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
7
Shares/Par
$
Value
(Cost
and
value
in
$000s)
CONSUMER
DISCRETIONARY
 6.1%
Broadline
Retail
 3.5%
Amazon.com (8)
10,777,538‌
2,487,671‌
2,487,671‌
Hotels,
Restaurants
&
Leisure
 2.6%
Starbucks (7)
11,969,549‌
1,007,956‌
Yum!
Brands (7)
5,214,386‌
788,832‌
1,796,788‌
Total
Consumer
Discretionary
4,284,459‌
CONSUMER
STAPLES
 0.6%
Beverages
 0.6%
Keurig
Dr
Pepper 
15,938,059‌
446,425‌
Total
Consumer
Staples
446,425‌
ENERGY
 1.0%
Oil,
Gas
&
Consumable
Fuels
 1.0%
Canadian
Natural
Resources 
20,878,050‌
706,722‌
Total
Energy
706,722‌
FINANCIALS
 6.3%
Capital
Markets
 1.2%
Ares
Coinvest
DBA
EP
Wealth,
Acquisition
Date:
11/24/25,
Cost $92,115 (3)(8)(9)
91,884,429‌
91,884‌
iCapital,
Acquisition
Date:
3/10/25
-
4/17/25,
Cost $98,805 (3)
(8)(9)
7,057,619‌
98,805‌
KKR 
5,096,312‌
649,678‌
840,367‌
Financial
Services
 2.4%
Mastercard,
Class
A (7)
1,534,658‌
876,106‌
Visa,
Class
A (7)
2,336,347‌
819,380‌
1,695,486‌
Insurance
 2.7%
Ethos
DBA
Broadstreet,
Acquisition
Date:
7/16/25,
Cost $578,073 (3)(8)(9)
578,072,525‌
578,073‌
Hockey
Parent
Holdings,
Acquisition
Date:
9/14/23
-
5/2/25,
Cost $701,066 (3)(8)(9)
552,165‌
701,995‌
Willis
Towers
Watson 
1,926,182‌
632,943‌
1,913,011‌
Total
Financials
4,448,864‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
8
Shares/Par
$
Value
(Cost
and
value
in
$000s)
HEALTH
CARE
 11.3%
Biotechnology
 0.8%
Arcellx (8)
2,759,084‌
179,892‌
BioNTech,
ADR (8)
1,443,737‌
137,444‌
Cytokinetics (8)
3,387,580‌
215,247‌
532,583‌
Health
Care
Equipment
&
Supplies
 4.4%
Abbott
Laboratories (7)
11,062,714‌
1,386,048‌
Becton
Dickinson
&
Company (7)
8,963,144‌
1,739,477‌
3,125,525‌
Health
Care
Providers
&
Services
 2.9%
Cencora 
2,727,140‌
921,092‌
McKesson 
394,611‌
323,695‌
UnitedHealth
Group 
2,513,212‌
829,636‌
2,074,423‌
Life
Sciences
Tools
&
Services
 2.2%
Danaher 
636,425‌
145,691‌
Revvity (5)
14,366,588‌
1,389,967‌
1,535,658‌
Pharmaceuticals
 1.0%
Eli
Lilly 
657,662‌
706,776‌
706,776‌
Total
Health
Care
7,974,965‌
INDUSTRIALS
&
BUSINESS
SERVICES
 1.4%
Industrial
Conglomerates
 0.4%
Bending
Spoons,
Class
C,
Acquisition
Date:
10/28/25,
Cost $172,761
(EUR) (3)(8)(9)
1,941,616‌
174,146‌
Live
Oak
Acquisition
V
SPAC/TeamShares
PIPE,
Class
A (5)(8)
(10)
11,637,732‌
107,882‌
282,028‌
Machinery
 1.0%
Ingersoll
Rand 
8,906,272‌
705,555‌
705,555‌
Total
Industrials
&
Business
Services
987,583‌
INFORMATION
TECHNOLOGY
 20.3%
Electronic
Equipment,
Instruments
&
Components
 0.7%
Amphenol,
Class
3,682,210‌
497,614‌
497,614‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
9
Shares/Par
$
Value
(Cost
and
value
in
$000s)
Semiconductors
&
Semiconductor
Equipment
 7.4%
Advanced
Micro
Devices (7)(8)
5,190,515‌
1,111,601‌
Broadcom 
3,290,541‌
1,138,856‌
NVIDIA (7)
15,999,190‌
2,983,849‌
5,234,306‌
Software
 8.3%
Aurora
Innovation (5)(8)
157,234,598‌
603,781‌
Microsoft (7)
6,501,026‌
3,144,026‌
PTC (5)(8)
7,220,266‌
1,257,843‌
Roper
Technologies (7)
555,966‌
247,477‌
Salesforce 
990,500‌
262,393‌
Workday,
Class
A (8)
1,705,958‌
366,406‌
5,881,926‌
Technology
Hardware,
Storage
&
Peripherals
 3.9%
Apple (7)
10,031,812‌
2,727,248‌
2,727,248‌
Total
Information
Technology
14,341,094‌
UTILITIES
 6.4%
Electric
Utilities
 1.2%
PPL 
24,540,452‌
859,407‌
859,407‌
Multi-Utilities
 5.2%
Ameren 
9,661,304‌
964,778‌
CenterPoint
Energy (5)
35,692,638‌
1,368,456‌
NiSource (5)
31,701,526‌
1,323,855‌
3,657,089‌
Total
Utilities
4,516,496‌
Total
Miscellaneous
Common
Stocks
 3.7% (11)
2,609,716‌
Total
Common
Stocks
(Cost
$31,928,893)
44,097,651‌
CONVERTIBLE
PREFERRED
STOCKS
 2.1%
CONSUMER
STAPLES
 0.3%
Beverages
 0.3%
Keurig
Dr
Pepper
PIPE,
Series
A,
Acquisition
Date:
12/24/25,
Cost $242,286 (3)(8)(9)(10)
237,535‌
237,535‌
Total
Consumer
Staples
237,535‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
10
Shares/Par
$
Value
(Cost
and
value
in
$000s)
FINANCIALS
 0.1%
Capital
Markets
 0.1%
KKR,
Series
D,
6.25%,
3/1/28 
719,787‌
37,314‌
Total
Financials
37,314‌
INFORMATION
TECHNOLOGY
 1.7%
Software
 1.7%
Anthropic,
Series
F-1,
Acquisition
Date:
8/29/25,
Cost $172,875 (3)(8)(9)
1,226,347‌
312,020‌
Waymo,
Series
A-2,
Acquisition
Date:
5/8/20,
Cost $183,922 (3)
(8)(9)
2,141,932‌
332,342‌
Waymo,
Series
B-2,
Acquisition
Date:
6/11/21,
Cost $16,282 (3)
(8)(9)
177,514‌
27,786‌
Waymo,
Series
C-2,
Acquisition
Date:
1/12/24
-
9/27/24,
Cost $279,599 (3)(8)(9)
3,575,381‌
540,240‌
Total
Information
Technology
1,212,388‌
Total
Convertible
Preferred
Stocks
(Cost
$930,599)
1,487,237‌
CORPORATE
BONDS
 7.2%
AmWINS
Group,
6.375%,
2/15/29 (1)
38,945,000‌
39,971‌
Avantor
Funding,
3.875%,
11/1/29 (1)
8,280,000‌
7,922‌
Avantor
Funding,
4.625%,
7/15/28 (1)
34,153,000‌
33,960‌
Booz
Allen
Hamilton,
4.00%,
7/1/29 (1)
23,437,000‌
22,934‌
Booz
Allen
Hamilton,
5.95%,
8/4/33 
34,614,000‌
36,149‌
Broadstreet
Partners
Group,
5.875%,
4/15/29 (1)
129,520,000‌
129,332‌
Capstone
Borrower,
8.00%,
6/15/30 (1)
30,351,000‌
31,265‌
CenterPoint
Energy,
VR,
5.95%,
4/1/56 (5)(12)
92,389,000‌
93,002‌
Crowdstrike
Holdings,
3.00%,
2/15/29 
5,722,000‌
5,489‌
Ellucian
Holdings,
6.50%,
12/1/29 (1)
44,662,000‌
45,639‌
Fair
Isaac,
6.00%,
5/15/33 (1)
46,755,000‌
47,947‌
Hilton
Domestic
Operating,
3.625%,
2/15/32 (1)
114,947,000‌
106,604‌
Hilton
Domestic
Operating,
3.75%,
5/1/29 (1)
93,694,000‌
91,099‌
Hilton
Domestic
Operating,
4.00%,
5/1/31 (1)
138,883,000‌
132,922‌
Hilton
Domestic
Operating,
4.875%,
1/15/30 
85,067,000‌
85,319‌
Hilton
Domestic
Operating,
5.50%,
3/31/34 (1)
58,318,000‌
58,771‌
Hilton
Domestic
Operating,
5.75%,
9/15/33 (1)
81,115,000‌
83,003‌
Hilton
Domestic
Operating,
5.875%,
4/1/29 (1)
45,179,000‌
46,209‌
Hilton
Worldwide
Finance,
4.875%,
4/1/27 
38,607,000‌
38,608‌
Hologic,
3.25%,
2/15/29 (1)
26,768,000‌
26,386‌
HUB
International,
5.625%,
12/1/29 (1)
74,890,000‌
74,973‌
HUB
International,
7.25%,
6/15/30 (1)
587,665,000‌
616,319‌
HUB
International,
7.375%,
1/31/32 (1)
327,386,000‌
343,530‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
11
Shares/Par
$
Value
(Cost
and
value
in
$000s)
IQVIA,
5.00%,
5/15/27 (1)
42,949,000‌
42,952‌
IQVIA,
6.50%,
5/15/30 (1)
27,385,000‌
28,421‌
KFC
Holding,
4.75%,
6/1/27 (1)
138,786,000‌
138,646‌
Korn
Ferry,
4.625%,
12/15/27 (1)
32,922,000‌
32,908‌
Life
Time,
6.00%,
11/15/31 (1)
34,095,000‌
34,872‌
Mirant,
EC,
7.90%,
7/15/09 (1)(3)(8)
16,000,000‌
—‌
MSCI,
5.25%,
9/1/35 
90,885,000‌
91,619‌
NiSource,
VR,
5.75%,
7/15/56 (5)(12)
181,094,000‌
182,497‌
PTC,
4.00%,
2/15/28 (1)(5)
41,117,000‌
40,490‌
Ryan
Specialty,
4.375%,
2/1/30 (1)
24,807,000‌
24,322‌
Ryan
Specialty,
5.875%,
8/1/32 (1)
65,952,000‌
67,437‌
SBA
Communications,
3.125%,
2/1/29 
114,808,000‌
109,715‌
SBA
Communications,
3.875%,
2/15/27 
102,069,000‌
101,143‌
SBA
Tower
Trust,
6.599%,
1/15/28 (1)
2,575,000‌
2,637‌
Service
Corp.
International,
3.375%,
8/15/30 
25,624,000‌
23,978‌
Service
Corp.
International,
4.625%,
12/15/27 
5,256,000‌
5,244‌
Service
Corp.
International,
5.75%,
10/15/32 
34,085,000‌
34,755‌
Six
Flags
Entertainment,
5.375%,
4/15/27 
68,764,000‌
68,445‌
Six
Flags
Entertainment,
5.50%,
4/15/27 (1)
63,759,000‌
63,527‌
Six
Flags
Entertainment,
6.50%,
10/1/28 
54,236,000‌
53,161‌
Surgery
Center
Holdings,
7.25%,
4/15/32 (1)
27,373,000‌
27,718‌
TransDigm,
4.625%,
1/15/29 
47,592,000‌
47,295‌
TransDigm,
6.25%,
1/31/34 (1)
11,838,000‌
12,281‌
TransDigm,
6.375%,
3/1/29 (1)
184,964,000‌
190,961‌
TransDigm,
6.375%,
5/31/33 (1)
175,517,000‌
180,071‌
TransDigm,
6.625%,
3/1/32 (1)
239,679,000‌
249,380‌
TransDigm,
6.75%,
8/15/28 (1)
28,464,000‌
29,011‌
TransDigm,
6.75%,
1/31/34 (1)
113,340,000‌
118,129‌
TransDigm,
7.125%,
12/1/31 (1)
106,169,000‌
111,347‌
USI,
7.50%,
1/15/32 (1)
130,072,000‌
136,416‌
Vail
Resorts,
5.625%,
7/15/30 (1)
20,535,000‌
20,875‌
Vail
Resorts,
6.50%,
5/15/32 (1)
40,770,000‌
42,335‌
Yum!
Brands,
3.625%,
3/15/31 
58,624,000‌
55,429‌
Yum!
Brands,
4.625%,
1/31/32 
102,997,000‌
101,000‌
Yum!
Brands,
4.75%,
1/15/30 (1)
46,930,000‌
47,033‌
Yum!
Brands,
5.35%,
11/1/43 
84,184,000‌
81,612‌
Yum!
Brands,
5.375%,
4/1/32 
121,510,000‌
123,212‌
Yum!
Brands,
6.875%,
11/15/37 
36,509,000‌
40,236‌
Total
Miscellaneous
Corporate
Bonds
 0.2% (11)
172,073‌
Total
Corporate
Bonds
(Cost
$4,979,185)
5,130,536‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
12
Shares/Par
$
Value
(Cost
and
value
in
$000s)
PREFERRED
STOCKS
 0.2%
FINANCIALS
 0.2%
Insurance
 0.2%
AH
Parent,
Series
A,
Acquisition
Date:
9/27/24,
Cost $140,396 (3)(9)
142,534‌
143,634‌
Total
Financials
143,634‌
UTILITIES
 0.0%
Electric
Utilities
 0.0%
CMS
Energy,
5.88%,
10/15/78 
19,289‌
437‌
Total
Utilities
437‌
Total
Preferred
Stocks
(Cost
$140,878)
144,071‌
U.S.
GOVERNMENT
AGENCY
OBLIGATIONS
(EXCLUDING
MORTGAGE-BACKED)
 16.3%
U.S.
Treasury
Obligations
 16.3%
U.S.
Treasury
Notes,
3.50%,
11/30/30 
2,374,042,000‌
2,352,527‌
U.S.
Treasury
Notes,
3.625%,
8/31/30 
1,123,688,400‌
1,120,791‌
U.S.
Treasury
Notes,
3.625%,
9/30/30 
1,128,000,000‌
1,124,739‌
U.S.
Treasury
Notes,
3.625%,
10/31/30 
2,518,500,000‌
2,510,433‌
U.S.
Treasury
Notes,
3.75%,
10/31/32 
708,000,000‌
701,252‌
U.S.
Treasury
Notes,
3.75%,
11/30/32 
546,338,000‌
540,875‌
U.S.
Treasury
Notes,
3.875%,
7/31/30 
2,219,307,000‌
2,237,859‌
U.S.
Treasury
Notes,
3.875%,
9/30/32 
879,000,000‌
877,627‌
11,466,103‌
Total
U.S.
Government
Agency
Obligations
(Excluding
Mortgage-Backed)
(Cost
$11,451,424)
11,466,103‌
SHORT-TERM
INVESTMENTS
 2.6%
Money
Market
Funds
 2.6%
T.
Rowe
Price
Government
Reserve
Fund,
3.77% (5)(13)
1,840,157,884‌
1,840,158‌
Total
Short-Term
Investments
(Cost
$1,840,158)
1,840,158‌
Total
Investments
in
Securities
100.7%
of
Net
Assets
(Cost
$58,151,525)
$
71,063,825‌
Shares/Par
and
Notional
Amount
are
denominated
in
U.S.
dollars
unless
otherwise
noted.
T.
ROWE
PRICE
Capital
Appreciation
Fund
13
.
.
.
.
.
.
.
.
.
.
(1)
Security
was
purchased
pursuant
to
Rule
144A
under
the
Securities
Act
of
1933
and
may
be
resold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers.
Total
value
of
such
securities
at
period-end
amounts
to
$3,619,789
and
represents
5.1%
of
net
assets.
(2)
Bank
loan
positions
may
involve
multiple
underlying
tranches.
In
those
instances,
the
position
presented
reflects
the
aggregate
of
those
respective
underlying
tranches
and
the
rate
presented
reflects
the
weighted
average
rate
of
the
settled
positions.
(3)
See
Note
2.
Level
3
in
fair
value
hierarchy.
(4)
All
or
a
portion
of
this
loan
is
unsettled
as
of
December
31,
2025.
The
interest
rate
for
unsettled
loans
will
be
determined
upon
settlement
after
period
end.
(5)
Affiliated
Companies
(6)
SEC
30-day
yield
(7)
At
December
31,
2025,
all
or
a
portion
of
this
security
is
pledged
as
collateral
and/or
margin
deposit
to
cover
future
funding
obligations.
(8)
Non-income
producing
(9)
Security
cannot
be
offered
for
public
resale
without
first
being
registered
under
the
Securities
Act
of
1933
and
related
rules
("restricted
security").
Acquisition
date
represents
the
day
on
which
an
enforceable
right
to
acquire
such
security
is
obtained
and
is
presented
along
with
related
cost
in
the
security
description.
The
fund
may
have
registration
rights
for
certain
restricted
securities.
Any
costs
related
to
such
registration
are
generally
borne
by
the
issuer.
The
aggregate
value
of
restricted
securities
(excluding
144A
holdings)
at
period
end
amounts
to
$3,238,460
and
represents
4.6%
of
net
assets.
(10)
All
or
a
portion
of
the
position
represents
an
unfunded
commitment;
a
liability
to
fund
the
commitment
has
been
recognized.
The
fund's
total
unfunded
commitments
at
December
31,
2025,
were
$349,353
and
were
valued
at
$345,417
(0.5%
of
net
assets).
(11)
The
identity
of
certain
securities
has
been
concealed
to
protect
the
fund
while
it
completes
a
purchase
or
selling
program
for
the
securities.
(12)
Security
is
a
fix-to-float
security,
which
carries
a
fixed
coupon
until
a
certain
date,
upon
which
it
switches
to
a
floating
rate.
Reference
rate
and
spread
are
provided
if
the
rate
is
currently
floating.
(13)
Seven-day
yield
1M
EURIBOR
One
month
EURIBOR
(Euro
interbank
offered
rate)
1M
TSFR
One
month
term
SOFR
(Secured
overnight
financing
rate)
3M
TSFR
Three
month
term
SOFR
(Secured
overnight
financing
rate)
ADR
American
Depositary
Receipts
EC
Escrow
CUSIP;
represents
a
beneficial
interest
in
a
residual
pool
of
assets;
the
amount
and
timing
of
future
distributions,
if
any,
is
uncertain;
when
presented,
interest
rate
and
maturity
date
are
those
of
the
original
security.
EUR
Euro
FRN
Floating
Rate
Note
OTC
Over-the-counter
T.
ROWE
PRICE
Capital
Appreciation
Fund
14
.
.
.
.
.
.
.
.
.
.
PIPE
Private
Investment
in
Public
Equity
SPAC
Special
Purpose
Acquisition
Company
VR
Variable
Rate;
rate
shown
is
effective
rate
at
period-end.
The
rates
for
certain
variable
rate
securities
are
not
based
on
a
published
reference
rate
and
spread
but
are
determined
by
the
issuer
or
agent
and
based
on
current
market
conditions.
T.
ROWE
PRICE
Capital
Appreciation
Fund
15
(Amounts
in
000s,
except
for
contracts)
OPTIONS
WRITTEN
 (0.3)%
OTC
Options
Written (0.3)%
Counterparty
Description
Contracts
Notional
Amount
$
Value
Bank
of
America
Abbott
Laboratories,
Call,
1/16/26
@
$130.00
6,176
77,379
(
244‌
)
Bank
of
America
Abbott
Laboratories,
Call,
1/16/26
@
$140.00
3,447
43,187
(
48‌
)
Bank
of
America
Abbott
Laboratories,
Call,
1/16/26
@
$145.00
3,080
38,589
(
14‌
)
Bank
of
America
Willis
Towers
Watson,
Call,
1/16/26
@
$330.00
668
21,951
(
327‌
)
Bank
of
America
Willis
Towers
Watson,
Call,
1/16/26
@
$340.00
668
21,951
(
119‌
)
Barclays
Bank
Advanced
Micro
Devices,
Call,
1/16/26
@
$175.00
3,447
73,821
(
13,805‌
)
Barclays
Bank
Advanced
Micro
Devices,
Call,
1/16/26
@
$180.00
3,447
73,821
(
12,168‌
)
Barclays
Bank
Apple,
Call,
1/16/26
@
$235.00
3,447
93,710
(
12,926‌
)
Barclays
Bank
Apple,
Call,
1/16/26
@
$245.00
3,447
93,710
(
9,514‌
)
Barclays
Bank
Canadian
Natural
Resources,
Call,
1/16/26
@
$32.50
10,342
35,008
(
1,319‌
)
Barclays
Bank
Canadian
Natural
Resources,
Call,
1/16/26
@
$35.00
10,342
35,008
(
207‌
)
Barclays
Bank
Mastercard,
Class
A,
Call,
1/16/26
@
$580.00
1,373
78,382
(
494‌
)
Barclays
Bank
Mastercard,
Class
A,
Call,
1/16/26
@
$585.00
1,331
75,984
(
302‌
)
Barclays
Bank
Mastercard,
Class
A,
Call,
1/16/26
@
$610.00
1,331
75,984
(
34‌
)
Barclays
Bank
Mastercard,
Class
A,
Call,
1/16/26
@
$620.00
685
39,105
(
12‌
)
Barclays
Bank
Mastercard,
Class
A,
Call,
1/16/26
@
$640.00
1,381
78,839
(
25‌
)
Barclays
Bank
Mastercard,
Class
A,
Call,
6/18/26
@
$670.00
1,381
78,839
(
732‌
)
Citibank
Amazon.com,
Call,
1/16/26
@
$250.00
3,447
79,564
(
107‌
)
Citibank
Amazon.com,
Call,
1/16/26
@
$260.00
3,447
79,564
(
33‌
)
Citibank
Eli
Lilly,
Call,
1/16/26
@
$850.00
267
28,694
(
6,077‌
)
T.
ROWE
PRICE
Capital
Appreciation
Fund
16
(Amounts
in
000s,
except
for
contracts)
Counterparty
Description
Contracts
Notional
Amount
$
Value
Citibank
Eli
Lilly,
Call,
1/16/26
@
$890.00
267
28,694
(
5,028‌
)
Goldman
Sachs
McKesson,
Call,
1/16/26
@
$660.00
515
42,245
(
8,351‌
)
Goldman
Sachs
McKesson,
Call,
1/16/26
@
$680.00
514
42,163
(
7,314‌
)
Goldman
Sachs
McKesson,
Call,
1/16/26
@
$760.00
690
56,600
(
4,461‌
)
Goldman
Sachs
McKesson,
Call,
1/16/26
@
$780.00
690
56,600
(
3,150‌
)
Goldman
Sachs
NVIDIA,
Call,
1/16/26
@
$190.00
3,792
70,721
(
1,479‌
)
Goldman
Sachs
NVIDIA,
Call,
1/16/26
@
$200.00
3,792
70,721
(
413‌
)
Goldman
Sachs
Visa,
Class
A,
Call,
1/16/26
@
$360.00
2,059
72,211
(
234‌
)
Goldman
Sachs
Visa,
Class
A,
Call,
1/16/26
@
$370.00
2,069
72,562
(
36‌
)
Goldman
Sachs
Visa,
Class
A,
Call,
1/16/26
@
$380.00
2,072
72,667
(
41‌
)
Goldman
Sachs
Visa,
Class
A,
Call,
1/16/26
@
$390.00
2,258
79,190
(
14‌
)
Goldman
Sachs
Visa,
Class
A,
Call,
1/16/26
@
$400.00
2,069
72,562
(
13‌
)
Goldman
Sachs
Visa,
Class
A,
Call,
6/18/26
@
$395.00
2,072
72,667
(
1,228‌
)
JPMorgan
Chase
Meta
Platforms,
Class
A,
Call,
1/16/26
@
$775.00
1,379
91,026
(
10‌
)
JPMorgan
Chase
Meta
Platforms,
Class
A,
Call,
1/16/26
@
$810.00
1,379
91,026
(
5‌
)
JPMorgan
Chase
Microsoft,
Call,
1/16/26
@
$565.00
1,379
66,691
(
1‌
)
JPMorgan
Chase
Microsoft,
Call,
1/16/26
@
$590.00
1,379
66,691
(
1‌
)
UBS
Investment
Bank
Alphabet,
Class
A,
Call,
1/16/26
@
$205.00
3,448
107,922
(
37,531‌
)
UBS
Investment
Bank
Alphabet,
Class
A,
Call,
1/16/26
@
$215.00
3,448
107,922
(
34,084‌
)
UBS
Investment
Bank
Alphabet,
Class
A,
Call,
1/15/27
@
$340.00
1,391
43,538
(
5,359‌
)
UBS
Investment
Bank
Alphabet,
Class
A,
Call,
1/15/27
@
$350.00
1,391
43,538
(
4,858‌
)
UBS
Investment
Bank
Alphabet,
Class
A,
Call,
1/15/27
@
$360.00
1,391
43,538
(
4,375‌
)
T.
ROWE
PRICE
Capital
Appreciation
Fund
17
(Amounts
in
000s,
except
for
contracts)
Counterparty
Description
Contracts
Notional
Amount
$
Value
UBS
Investment
Bank
Amphenol,
Class
A,
Call,
1/16/26
@
$115.00
1,992
26,920
(
4,173‌
)
UBS
Investment
Bank
Amphenol,
Class
A,
Call,
1/16/26
@
$120.00
1,992
26,920
(
3,207‌
)
UBS
Investment
Bank
Danaher,
Call,
1/16/26
@
$220.00
2,758
63,136
(
3,144‌
)
UBS
Investment
Bank
Danaher,
Call,
1/16/26
@
$330.00
3,437
78,680
(
180‌
)
Wells
Fargo
Bank
Ingersoll
Rand,
Call,
1/16/26
@
$95.00
4,826
38,232
(
229‌
)
Wells
Fargo
Bank
Ingersoll
Rand,
Call,
1/16/26
@
$100.00
4,826
38,232
(
181‌
)
Wells
Fargo
Bank
Starbucks,
Call,
1/16/26
@
$100.00
5,515
46,442
(
17‌
)
Wells
Fargo
Bank
Starbucks,
Call,
1/16/26
@
$105.00
13,112
110,416
(
33‌
)
Wells
Fargo
Bank
Starbucks,
Call,
1/16/26
@
$125.00
2,959
24,918
(
1‌
)
Wells
Fargo
Bank
Workday,
Class
A,
Call,
1/16/26
@
$260.00
2,758
59,236
(
76‌
)
Wells
Fargo
Bank
Workday,
Class
A,
Call,
1/16/26
@
$270.00
2,758
59,236
(
7‌
)
Wells
Fargo
Bank
Yum!
Brands,
Call,
1/16/26
@
$145.00
2,402
36,337
(
1,693‌
)
Wells
Fargo
Bank
Yum!
Brands,
Call,
1/16/26
@
$160.00
4,539
68,666
(
136‌
)
Wells
Fargo
Bank
Yum!
Brands,
Call,
1/16/26
@
$165.00
1,382
20,907
(
14‌
)
Total
Options
Written
(Premiums
$(135,388))
$
(
189,584‌
)
T.
ROWE
PRICE
Capital
Appreciation
Fund
18
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
year
ended
December
31,
2025.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
Aurora
Innovation 
$
(
3,850‌
)
$
(
356,057‌
)
$
—‌
CenterPoint
Energy 
23,340‌
179,695‌
27,699‌
CenterPoint
Energy,
VR,
5.95%,
4/1/56 
—‌
556‌
1,344‌
CMS
Energy,
5.875%,
10/15/78 
(
2,747‌
)
2,412‌
580‌
Ethos
DBA
Broadstreet 
—‌
—‌
—‌
Live
Oak
Acquisition
V
SPAC/TeamShares
PIPE,
Class
—‌
815‌
—‌
NiSource 
5,415‌
95,561‌
23,645‌
NiSource,
VR,
5.75%,
7/15/56 
—‌
1,521‌
1,607‌
PTC 
68,655‌
(
51,840‌
)
—‌
PTC,
4.00%,
2/15/28 
—‌
1,323‌
1,488‌
Revvity 
193‌
(
209,277‌
)
3,949‌
T.
Rowe
Price
Institutional
Floating
Rate
Fund
-
Institutional
Class,
6.59% 
—‌
(
6,803‌
)
68,285‌
T.
Rowe
Price
Government
Reserve
Fund,
3.77%
—‌
—‌
140,331‌
Affiliates
not
held
at
period
end
116,771‌
(
231,845‌
)
2,027‌
Totals
$
207,777‌
#
$
(
573,939‌
)
$
270,955‌
+
T.
ROWE
PRICE
Capital
Appreciation
Fund
19
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
AFFILIATED
COMPANIES
(CONTINUED)
($000s)
Supplementary
Investment
Schedule
Affiliate
Value
12/31/24
Purchase
Cost
Sales
Cost
Value
12/31/25
Aurora
Innovation 
$
844,038‌
$
164,082‌
$
48,282‌
$
603,781‌
CenterPoint
Energy 
*
386,158‌
164,365‌
1,368,456‌
CenterPoint
Energy,
VR,
5.95%,
4/1/56 
—‌
92,446‌
—‌
93,002‌
CMS
Energy,
5.875%,
10/15/78 
27,213‌
—‌
29,188‌
*
CMS
Energy,
5.875%,
3/1/79 
34‌
—‌
37‌
—‌
Ethos
DBA
Broadstreet 
—‌
578,073‌
—‌
*
Fortive 
1,606,345‌
—‌
1,374,501‌
—‌
Live
Oak
Acquisition
V
SPAC/
TeamShares
PIPE,
Class
—‌
107,067‌
—‌
107,882‌
NiSource 
*
951,406‌
233,049‌
1,323,855‌
NiSource,
VR,
5.75%,
7/15/56 
—‌
180,976‌
—‌
182,497‌
PTC 
1,306,781‌
548,746‌
545,844‌
1,257,843‌
PTC,
4.00%,
2/15/28 
28,259‌
10,916‌
8‌
40,490‌
Revvity 
1,468,645‌
130,740‌
141‌
1,389,967‌
Revvity,
3.30%,
9/15/29 
8,615‌
—‌
8,611‌
—‌
T.
Rowe
Price
Institutional
Floating
Rate
Fund
-
Institutional
Class,
6.59% 
919,663‌
68,101‌
—‌
980,961‌
T.
Rowe
Price
Government
Reserve
Fund,
3.77%
2,718,235‌
¤
¤
1,840,158‌
Total
$
9,188,892‌
^
#
Capital
gain
distributions
from
underlying
Price
funds
represented
$0
of
the
net
realized
gain
(loss).
+
Investment
income
comprised
$266,422
of
dividend
income
and
$4,533
of
interest
income.
*
On
the
date
indicated,
issuer
was
held
but
not
considered
an
affiliated
company.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$8,784,356.
T.
ROWE
PRICE
Capital
Appreciation
Fund
December
31,
2025
Statement
of
Assets
and
Liabilities
20
($000s,
except
shares
and
per
share
amounts)
Assets
Investments
in
securities,
at
value
(cost
$58,151,525)
$
71,063,825‌
Interest
and
dividends
receivable
201,163‌
Receivable
for
shares
sold
84,136‌
Cash
55,768‌
Foreign
currency
(cost
$31,931)
32,308‌
Receivable
for
investment
securities
sold
17,191‌
Other
assets
723‌
Total
assets
71,455,114‌
Liabilities
Payable
for
investment
securities
purchased
580,309‌
Options
written
(premiums
$135,388)
189,584‌
Payable
for
shares
redeemed
57,992‌
Investment
management
fees
payable
33,592‌
Due
to
affiliates
735‌
Payable
to
directors
51‌
Other
liabilities
4,115‌
Total
liabilities
866,378‌
NET
ASSETS
$
70,588,736‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
December
31,
2025
Statement
of
Assets
and
Liabilities
21
($000s,
except
shares
and
per
share
amounts)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Net
Assets
Consist
of:
Total
distributable
earnings
(loss)
$
13,511,656‌
Paid-in
capital
applicable
to
1,975,429,938
shares
of
$0.0001
par
value
capital
stock
outstanding;
4,000,000,000
shares
authorized
57,077,080‌
NET
ASSETS
$
70,588,736‌
NET
ASSET
VALUE
PER
SHARE
Investor
Class
(Net
assets:
$37,424,005;
Shares
outstanding:
1,046,904,507)
$
35.75‌
Advisor
Class
(Net
assets:
$828,902;
Shares
outstanding:
23,627,883)
$
35.08‌
I
Class
(Net
assets:
$32,335,829;
Shares
outstanding:
904,897,548)
$
35.73‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
Statement
of
Operations
22
($000s)
Year
Ended
12/31/25
Investment
Income
(Loss)
Income
.
  Interest
$
1,115,727‌
Dividend
(net
of
foreign
taxes
of
$6,192)
610,600‌
Other
16‌
Total
income
1,726,343‌
Expenses
Investment
management
394,375‌
Shareholder
servicing
Investor
Class
$
49,945‌
Advisor
Class
1,240‌
I
Class
3,022‌
54,207‌
Rule
12b-1
fees
Advisor
Class
2,016‌
Prospectus
and
shareholder
reports
Investor
Class
489‌
Advisor
Class
18‌
I
Class
279‌
786‌
Registration
1,266‌
Custody
and
accounting
1,236‌
Directors
210‌
Legal
and
audit
155‌
Miscellaneous
210‌
Waived
/
paid
by
Price
Associates
(
17,210‌
)
Total
expenses
437,251‌
Net
investment
income
1,289,092‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
Statement
of
Operations
23
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Year
Ended
12/31/25
Realized
and
Unrealized
Gain
/
Loss
Net
realized
gain
(loss)
Securities
5,135,595‌
Options
written
14,977‌
Foreign
currency
transactions
2,122‌
Net
realized
gain
5,152,694‌
Change
in
net
unrealized
gain
/
loss
Securities
1,586,568‌
Options
written
(
75,993‌
)
Other
assets
and
liabilities
denominated
in
foreign
currencies
1,716‌
Change
in
net
unrealized
gain
/
loss
1,512,291‌
Net
realized
and
unrealized
gain
/
loss
6,664,985‌
INCREASE
IN
NET
ASSETS
FROM
OPERATIONS
$
7,954,077‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
Statement
of
Changes
in
Net
Assets
24
($000s)
Year
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Ended
.
.
.
.
.
.
.
.
.
.
.
.
.
.
12/31/25
12/31/24
Increase
(Decrease)
in
Net
Assets
Operations
Net
investment
income
$
1,289,092‌
$
1,408,391‌
Net
realized
gain
5,152,694‌
5,326,126‌
Change
in
net
unrealized
gain
/
loss
1,512,291‌
588,851‌
Increase
in
net
assets
from
operations
7,954,077‌
7,323,368‌
Distributions
to
shareholders
Net
earnings
Investor
Class
(
3,059,499‌
)
(
3,313,494‌
)
Advisor
Class
(
66,846‌
)
(
74,183‌
)
I
Class
(
2,691,447‌
)
(
2,755,238‌
)
Decrease
in
net
assets
from
distributions
(
5,817,792‌
)
(
6,142,915‌
)
Capital
share
transactions
*
Shares
sold
Investor
Class
5,929,693‌
5,686,733‌
Advisor
Class
81,487‌
93,884‌
I
Class
4,886,792‌
5,045,061‌
Distributions
reinvested
Investor
Class
2,977,021‌
3,228,830‌
Advisor
Class
65,431‌
72,939‌
I
Class
2,578,270‌
2,649,688‌
Shares
redeemed
Investor
Class
(
7,513,960‌
)
(
6,368,311‌
)
Advisor
Class
(
134,748‌
)
(
152,568‌
)
I
Class
(
4,653,365‌
)
(
3,667,479‌
)
Increase
in
net
assets
from
capital
share
transactions
4,216,621‌
6,588,777‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
Statement
of
Changes
in
Net
Assets
25
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Year
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Ended
.
.
.
.
.
.
.
.
.
.
.
.
.
.
12/31/25
12/31/24
Net
Assets
Increase
during
period
6,352,906‌
7,769,230‌
Beginning
of
period
64,235,830‌
56,466,600‌
End
of
period
$
70,588,736‌
$
64,235,830‌
*Share
information
(000s)
Shares
sold
Investor
Class
162,372‌
157,250‌
Advisor
Class
2,280‌
2,647‌
I
Class
134,062‌
139,988‌
Distributions
reinvested
Investor
Class
84,455‌
93,265‌
Advisor
Class
1,891‌
2,143‌
I
Class
73,163‌
76,581‌
Shares
redeemed
Investor
Class
(
206,716‌
)
(
176,203‌
)
Advisor
Class
(
3,762‌
)
(
4,282‌
)
I
Class
(
128,185‌
)
(
101,158‌
)
Increase
in
shares
outstanding
119,560‌
190,231‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
NOTES
TO
FINANCIAL
STATEMENTS
26
T.
Rowe
Price
Capital
Appreciation
Fund,
Inc. (the
corporation)
is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act).
The
Capital
Appreciation
Fund
(the
fund)
is a
diversified, open-end
management
investment
company
established
by
the
corporation. The
fund
seeks long-term
capital
appreciation
by
investing
primarily
in
common
stocks.
It
may
also
hold
fixed-income
and
other
securities
to
help
preserve
principal
value.
The
fund
has three classes
of
shares:
the
Capital
Appreciation
Fund
(Investor
Class),
the
Capital
Appreciation
Fund–Advisor
Class
(Advisor
Class)
and
the
Capital
Appreciation
Fund–I
Class
(I
Class).
Advisor
Class
shares
are
sold
only
through
various
brokers
and
other
financial
intermediaries.
I
Class
shares
require
a
$500,000
initial
investment
minimum,
although
the
minimum
generally
is
waived
or
reduced
for
financial
intermediaries,
eligible
retirement
plans,
and
certain
other
accounts.
The
Advisor
Class
operates
under
a
Board-approved
Rule
12b-1
plan
pursuant
to
which
the
class
compensates
financial
intermediaries
for
distribution,
shareholder
servicing,
and/or
certain
administrative
services;
the
Investor
and
I
Classes
do
not
pay
Rule
12b-1
fees. Each
class
has
exclusive
voting
rights
on
matters
related
solely
to
that
class;
separate
voting
rights
on
matters
that
relate
to
all
classes;
and,
in
all
other
respects,
the
same
rights
and
obligations
as
the
other
classes. 
NOTE
1
-
SIGNIFICANT
ACCOUNTING
POLICIES 
Basis
of
Preparation
 The fund
is
an
investment
company
and
follows
accounting
and
reporting
guidance
in
the
Financial
Accounting
Standards
Board
(FASB)
Accounting
Standards
Codification
Topic
946
(ASC
946).
The
accompanying
financial
statements
were
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP),
including,
but
not
limited
to,
ASC
946.
GAAP
requires
the
use
of
estimates
made
by
management.
Management
believes
that
estimates
and
valuations
are
appropriate;
however,
actual
results
may
differ
from
those
estimates,
and
the
valuations
reflected
in
the
accompanying
financial
statements
may
differ
from
the
value
ultimately
realized
upon
sale
or
maturity.
Investment
Transactions,
Investment
Income,
and
Distributions
 Investment
transactions
are
accounted
for
on
the
trade
date
basis.
Income
and
expenses
are
recorded
on
the
accrual
basis.
Realized
gains
and
losses
are
reported
on
the
identified
cost
basis. Premiums
and
discounts
on
debt
securities
are
amortized
for
financial
reporting
purposes. Paydown
gains
and
losses
are
T.
ROWE
PRICE
Capital
Appreciation
Fund
27
recorded
as
an
adjustment
to
interest
income. Income
tax-related
interest
and
penalties,
if
incurred,
are
recorded
as
income
tax
expense. Dividends
received
from other
investment
companies are
reflected
as
dividend income;
capital
gain
distributions
are
reflected
as
realized
gain/loss. Dividend
income and
capital
gain
distributions
are
recorded
on
the
ex-dividend
date. Distributions
from
REITs
are
initially
recorded
as
dividend
income
and,
to
the
extent
such
represent
a
return
of
capital
or
capital
gain
for
tax
purposes,
are
reclassified
when
such
information
becomes
available. Non-cash
dividends,
if
any,
are
recorded
at
the
fair
market
value
of
the
asset
received. Proceeds
from
litigation
payments,
if
any,
are
included
in
either
net
realized
gain
(loss)
or
change
in
net
unrealized
gain/loss
from
securities. Distributions
to
shareholders
are
recorded
on
the
ex-dividend
date. Income
distributions,
if
any,
are
declared
and
paid
by
each
class annually. A
capital
gain
distribution,
if
any, may
also
be
declared
and
paid
by
the
fund
annually.
Currency
Translation
 Assets,
including
investments,
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Purchases
and
sales
of
securities,
income,
and
expenses
are
translated
into
U.S.
dollars
at
the
prevailing
exchange
rate
on
the
respective
date
of
such
transaction.
The
effect
of
changes
in
foreign
currency
exchange
rates
on
realized
and
unrealized
security
gains
and
losses
is
not
bifurcated
from
the
portion
attributable
to
changes
in
market
prices.
Class
Accounting
 Shareholder
servicing,
prospectus,
and
shareholder
report
expenses
incurred
by
each
class
are
charged
directly
to
the
class
to
which
they
relate.
Expenses
common
to
all
classes,
investment
income,
and
realized
and
unrealized
gains
and
losses
are
allocated
to
the
classes
based
upon
the
relative
daily
net
assets
of
each
class.
The
Advisor
Class
pays
Rule
12b-1
fees,
in
an
amount
not
exceeding
0.25%
of
the
class’s
average
daily
net
assets.
In-Kind
Redemptions
 In
accordance
with
guidelines
described
in
the
fund’s
prospectus,
and
when
considered
to
be
in
the
best
interest
of
all
shareholders,
the
fund
may
distribute
portfolio
securities
rather
than
cash
as
payment
for
a
redemption
of
fund
shares
(in-kind
redemption).
Gains
and
losses
realized
on
in-kind
redemptions
are
not
recognized
for
tax
purposes
and
are
reclassified
from
undistributed
realized
gain
(loss)
to
paid-in
capital.
During
the
year ended
December
31,
2025,
the
fund
realized
$5,038,000 of
net
gain
on
$12,242,000
of
in-kind
redemptions.
T.
ROWE
PRICE
Capital
Appreciation
Fund
28
Capital
Transactions
 Each
investor’s
interest
in
the
net
assets
of
the
fund
is
represented
by
fund
shares.
The
fund’s
net
asset
value
(NAV)
per
share
is
computed
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
Eastern
time,
each
day
the
NYSE
is
open
for
business.
However,
the
NAV
per
share
may
be
calculated
at
a
time
other
than
the
normal
close
of
the
NYSE
if
trading
on
the
NYSE
is
restricted,
if
the
NYSE
closes
earlier,
or
as
may
be
permitted
by
the
SEC.
Purchases
and
redemptions
of
fund
shares
are
transacted
at
the
next-computed
NAV
per
share,
after
receipt
of
the
transaction
order
by
T.
Rowe
Price
Associates,
Inc.,
or
its
agents.
Indemnification
 In
the
normal
course
of
business, the
fund
may
provide
indemnification
in
connection
with
its
officers
and
directors,
service
providers,
and/or
private
company
investments. The
fund’s
maximum
exposure
under
these
arrangements
is
unknown;
however,
the
risk
of
material
loss
is
currently
considered
to
be
remote.
NOTE
2
-
VALUATION 
Fair
Value
  The
fund’s
financial
instruments
are
valued
at
the
close
of
the
NYSE
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The fund’s
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund’s
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
performing
fair
value
determinations:
assesses
and
manages
valuation
risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee. The
Valuation
Designee provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
T.
ROWE
PRICE
Capital
Appreciation
Fund
29
Level
2
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
unobservable
inputs
(including
the Valuation
Designee’s assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques 
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-
counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the Valuation
Designee
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of
the
fund’s portfolio
securities.
Each
business
day,
the
Valuation
Designee uses
information
from
outside
pricing
services
to
evaluate
the
quoted
prices
of
portfolio
securities
and,
if
appropriate,
decides whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
T.
ROWE
PRICE
Capital
Appreciation
Fund
30
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The Valuation
Designee
uses
outside
pricing
services
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The Valuation
Designee
cannot
predict
how
often
it
will
use
quoted
prices
or how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
Debt
securities
are
generally traded
in
the over-the-counter
(OTC)
market
and
are
valued
at
prices
furnished
by
independent
pricing
services
or
by
broker
dealers
who
make
markets
in
such
securities.
When
valuing
securities,
the
independent
pricing
services
consider
factors
such
as,
but
not
limited
to,
the
yield
or
price
of
bonds
of
comparable
quality,
coupon,
maturity,
and
type,
as
well
as
prices
quoted
by
dealers
who
make
markets
in
such
securities.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Listed
options,
and
OTC
options
with
a
listed
equivalent,
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
and
exchange-traded
options
on
futures
contracts
are
valued
at
closing
settlement
prices.
Assets
and
liabilities
other
than
financial
instruments,
including
short-
term
receivables
and
payables,
are
carried
at
cost,
or
estimated
realizable
value,
if
less,
which
approximates
fair
value.
Investments
for
which
market
quotations are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee.
The
Valuation
Designee
has
adopted
methodologies
for
determining
the
fair
value
of
investments
for
which
market
quotations
are
not
readily
available
or
deemed
unreliable,
including
the
use
of
other
pricing
sources.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Designee typically
will
afford
the
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Designee may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions. Fair
value
prices
determined
T.
ROWE
PRICE
Capital
Appreciation
Fund
31
by
the
Valuation
Designee could
differ
from
those
of
other
market
participants,
and
it
is
possible
that
the
fair
value
determined
for
a
security
may
be
materially
different
from
the
value
that
could
be
realized
upon
the
sale
of
that
security.
Valuation
Inputs
  The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
December
31,
2025
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments): 
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Fixed
Income
Securities
1
$
$
11,505,337
$
$
11,505,337
Bank
Loans
5,673,853
204,021
5,877,874
Bond
Funds
980,961
980,961
Common
Stocks
42,344,866
107,882
1,644,903
44,097,651
Convertible
Preferred
Stocks
37,314
1,449,923
1,487,237
Corporate
Bonds
5,130,536
5,130,536
Preferred
Stocks
437
143,634
144,071
Short-Term
Investments
1,840,158
1,840,158
Total
$
45,203,736
$
22,417,608
$
3,442,481
$
71,063,825
Liabilities
Options
Written
$
$
189,584
$
$
189,584
1
Includes
Asset-Backed
Securities
and
U.S.
Government
Agency
Obligations
(Excluding
Mortgage-Backed).
T.
ROWE
PRICE
Capital
Appreciation
Fund
32
Following
is
a
reconciliation
of
the
fund’s
Level
3
holdings
for
the
year ended
December
31,
2025.
Gain
(loss)
reflects
both
realized
and
change
in
unrealized
gain/loss
on
Level
3
holdings
during
the
period,
if
any,
and
is
included
on
the
accompanying
Statement
of
Operations.
The
change
in
unrealized
gain/loss
on
Level
3
instruments
held
at
December
31,
2025,
totaled $563,644,000 for
the
year ended
December
31,
2025.
In
accordance
with
GAAP,
the
following
table
provides
quantitative
information
about
significant
unobservable
inputs
used
to
determine
the
fair
valuations
of
the
fund’s
Level
3
assets,
by
class
of
financial
instrument.
Because
the
Valuation
Designee considers
a
wide
variety
of
factors
and
($000s)
Beginning
Balance
12/31/24
Gain
(Loss)
During
Period
Total
Purchases
Total
Sales
Ending
Balance
12/31/25
Investment
in
Securities
Bank
Loans
$
—‌
$
1,153‌
$
203,239‌
$
(371‌)
$
204,021‌
Common
Stocks
135,379‌
(10,240‌)
1,519,764‌
—‌
1,644,903‌
Convertible
Preferred
Stocks
465,977‌
568,785‌
415,161‌
—‌
1,449,923‌
Corporate
Bonds
—‌
—‌
—‌
—‌
—‌
Preferred
Stocks
139,708‌
3,926‌
—‌
—‌
143,634‌
Total
$
741,064‌
$
563,624‌
$
2,138,164‌
$
(371‌)
$
3,442,481‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
33
inputs,
both
observable
and
unobservable,
in
determining
fair
values,
the
unobservable
inputs
presented
do
not
reflect
all
inputs
significant
to
the
fair
value
determination.
Investments
in
Securities
Value
(000s)
Valuation
Technique(s)+
Significant
Unobservable
Input(s)
Value
or
Range
of
Input(s)
Weighted
Average
of
Input(s)*
Impact
to
Valuation
from
an
Increase
in
Input**
Bank
Loans
$204,021
Pricing
service
—#
—#
—#
—#
Common
Stocks
$1,644,903
Recent
comparable
transaction
price(s)
—#
—#
—#
—#
Market
comparable
Enterprise
value
to
EBITDA
multiple
17.1x
17.1x
Increase
Discount
to
public
company
multiples
12%
12%
Decrease
Convertible
Preferred
Stocks
$1,449,923
Recent
comparable
transaction
price(s)
—#
—#
—#
—#
Market
comparable
Enterprise
value
to
sales
multiple
12.2x
-
27.5x
19.9x
Increase
Sales
growth
rate
66%
66%
Increase
Enterprise
value
to
EBITDA
multiple
8.9x
-
26.2x
17.6x
Increase
EBITDA
growth
rate
170%
170%
Increase
Cost
of
capital
30%
30%
Decrease
T.
ROWE
PRICE
Capital
Appreciation
Fund
34
+
Valuation
techniques
may
change
in
order
to
reflect the
Valuation
Designee’s
judgment
of
current
market
participant
assumptions. 
*
Unobservable
inputs
were
weighted
by
the
relative
fair
value
of
the
instruments.
**
Represents
the
directional
change
in
the
fair
value
of
the
Level
3
investment(s)
that
would
have
resulted
from
an
increase
in
the
corresponding
input
at
period
end.
A
decrease
in
the
unobservable
input
would
have
had
the
opposite
effect.
Significant
increases
and
decreases
in
these
inputs
in
isolation
could
result
in
significantly
higher
or
lower
fair
value
measurements.
#
No
quantitative
unobservable
inputs
significant
to
the
valuation
technique
were
created
by
the
Valuation
Designee.
NOTE
3
-
DERIVATIVE
INSTRUMENTS 
During
the
year ended
December
31,
2025,
the
fund
invested
in
derivative
instruments.
As
defined
by
GAAP,
a
derivative
is
a
financial
instrument
whose
value
is
derived
from
an
underlying
security
price,
foreign
exchange
rate,
interest
rate,
index
of
prices
or
rates,
or
other
variable;
it
requires
little
or
no
initial
investment
and
permits
or
requires
net
settlement
or
delivery
of
cash
or
other
assets.
The
fund
invests
in
derivatives
only
if
the
expected
risks
and
rewards
are
consistent
with
its
investment
objectives,
policies,
and
overall
risk
profile,
as
described
in
its
prospectus
and
Statement
of
Additional
Information.
The
fund
may
use
derivatives
for
a
variety
of
purposes
and
may
use
them
to
establish
both
long
and
short
positions
within
the
fund’s
portfolio.
Potential
uses
include
to
hedge
against
declines
in
principal
value,
increase
yield,
invest
in
an
asset
with
greater
efficiency
and
at
a
lower
cost
than
is
possible
through
direct
investment,
to
enhance
return,
or
to
adjust
credit
exposure.
The
risks
associated
Investments
in
Securities
Value
(000s)
Valuation
Technique(s)+
Significant
Unobservable
Input(s)
Value
or
Range
of
Input(s)
Weighted
Average
of
Input(s)*
Impact
to
Valuation
from
an
Increase
in
Input**
Discount
for
lack
of
marketability
10%
10%
Decrease
Corporate
Bonds
$—
Recent
comparable
transaction
price(s)
Discount
for
uncertainty
100%
100%
Decrease
Preferred
Stocks
$143,634
Market
comparable
Relative
Value
—#
—#
—#
T.
ROWE
PRICE
Capital
Appreciation
Fund
35
with
the
use
of
derivatives
are
different
from,
and
potentially
much
greater
than,
the
risks
associated
with
investing
directly
in
the
instruments
on
which
the
derivatives
are
based.
The
fund
values
its
derivatives
at
fair
value
and
recognizes
changes
in
fair
value
currently
in
its
results
of
operations.
Accordingly,
the
fund
does
not
follow
hedge
accounting,
even
for
derivatives
employed
as
economic
hedges.
Generally,
the
fund
accounts
for
its
derivatives
on
a
gross
basis.
It
does
not
offset
the
fair
value
of
derivative
liabilities
against
the
fair
value
of
derivative
assets
on
its
financial
statements,
nor
does
it
offset
the
fair
value
of
derivative
instruments
against
the
right
to
reclaim
or
obligation
to
return
collateral.
The
following
table
summarizes
the
fair
value
of
the
fund’s
derivative
instruments
held
as
of
December
31,
2025,
and
the
related
location
on
the
accompanying
Statement
of
Assets
and
Liabilities,
presented
by
primary
underlying
risk
exposure: 
Additionally,
the
amount
of
gains
and
losses
on
derivative
instruments
recognized
in
fund
earnings
during
the
year ended
December
31,
2025,
and
the
related
location
on
the
accompanying
Statement
of
Operations
is
summarized
in
the
following
table
by
primary
underlying
risk
exposure: 
($000s)
Location
on
Statement
of
Assets
and
Liabilities
Fair
Value
Liabilities
Equity
derivatives
Options
Written
$
189,584‌
Total
$
189,584‌
($000s)                                              
Location
of
Gain
(Loss)
on
Statement
of
Operations
Options
Written
Realized
Gain
(Loss)
Equity
derivatives
$
14,977‌
Total
$
14,977‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
36
Counterparty
Risk
and
Collateral
 The
fund
invests
in
derivatives,
such
as
non-cleared
bilateral
swaps,
forward
currency
exchange
contracts,
and/or
OTC
options,
that
are
transacted
and
settle
directly
with
a
counterparty
(bilateral
derivatives),
and
thereby
may
expose
the
fund
to
counterparty
risk.
To
mitigate
this
risk,
the
fund
has
entered
into
master
netting
arrangements
(MNAs)
with
certain
counterparties
that
permit
net
settlement
under
specified
conditions
and,
for
certain
counterparties,
also
require
the
exchange
of
collateral
to
cover
mark-to-market
exposure.
MNAs
may
be
in
the
form
of
International
Swaps
and
Derivatives
Association
master
agreements
(ISDAs),
with
a
Credit
Support
Annex
(CSA),
if
any,
that
governs
the
collateralization
process,
or
foreign
exchange
letter
agreements
(FX
letters).
MNAs
govern
the
ability
to
offset
amounts
the
fund
owes
a
counterparty
against
amounts
the
counterparty
owes
the
fund
(net
settlement).
Both
ISDAs
and
FX
letters
generally
allow
termination
of
transactions
and
net
settlement
upon
the
occurrence
of
contractually
specified
events,
such
as
failure
to
pay
or
bankruptcy.
In
addition,
ISDAs
specify
other
events,
such
as
Additional
Termination
Events, the
occurrence
of
which
would
allow
one
of
the
parties
to
terminate.
For
example,
a
downgrade
in
credit
rating
of
a
counterparty
below
a
specified
rating
would
allow
the
fund
to
terminate,
while
a
decline
in
the
fund’s
net
assets
of
more
than
a
specified
percentage
would
allow
the
counterparty
to
terminate.
Upon
termination,
all
transactions
with
that
counterparty
would
be
liquidated
and
a
net
termination
amount
determined.
ISDAs
typically
include
collateral
agreements,
such
as
a
CSA,
whereas
FX
letters
do
not.
Collateral
requirements
are
determined
daily
based
on
the
net
aggregate
unrealized
gain
or
loss
on
all
bilateral
derivatives
with
each
counterparty,
subject
to
minimum
transfer
amounts
that
typically
range
from
$100,000
to
$250,000.
Any
additional
collateral
required
due
to
changes
in
security
values
is
typically
transferred
the
next
business
day.
($000s)                                              
Location
of
Gain
(Loss)
on
Statement
of
Operations
Options
Written
Change
in
Unrealized
Gain
(Loss)
Equity
derivatives
$
(75,993‌)
Total
$
(75,993‌)
T.
ROWE
PRICE
Capital
Appreciation
Fund
37
Collateral may
be
in
the
form
of
cash,
debt
securities
issued
by
the
U.S.
government
or
related
agencies,
or
equity
securities,
although
other
securities
may
be
used
depending
on
the
terms
outlined
in
the
applicable
MNA.
Cash
posted
by
the
fund
is
reflected
as
cash
deposits
in
the
accompanying
financial
statements
and
generally
is
restricted
from
withdrawal
by
the
fund;
securities
posted
by
the
fund
are
so
noted
in
the
accompanying
Portfolio
of
Investments;
both
remain
in
the
fund’s
assets.
Collateral
pledged
by
counterparties
is
not
included
in
the
fund’s
assets
because
the
fund
does
not
obtain
effective
control
over
those
assets.
For
bilateral
derivatives,
collateral
posted
or
received
by
the
fund
is
held
in
a
segregated
account
at
the
fund’s
custodian.
While
typically
not
sold
in
the
same
manner
as
equity
or
fixed
income
securities,
OTC
and
bilateral
derivatives
may
be
unwound
with
counterparties
or
transactions
assigned
to
other
counterparties
to
allow
the
fund
to
exit
the
transaction.
This
ability
is
subject
to
the
liquidity
of
underlying
positions. As
of
December
31,
2025,
securities
valued
at $56,804,000
had
been
posted
by
the
fund
to
counterparties
for
bilateral
derivatives. As
of
December
31,
2025,
no
collateral
was
pledged
by
counterparties
to
the
fund
for
bilateral
derivatives.
Options 
 The
fund
is
subject
to equity
price
risk in
the
normal
course
of
pursuing
its
investment
objectives
and
uses
options
to
help
manage
such
risk.
The
fund
may
use
options
to
manage
exposure
to
security
prices,
interest
rates,
foreign
currencies,
and
credit
quality;
as
an
efficient
means
of
adjusting
exposure
to
all
or
a
part
of
a
target
market;
to
enhance
income;
as
a
cash
management
tool;
or
to
adjust
credit
exposure.
The
fund
may
buy
or
sell
options
that
can
be
settled
either
directly
with
the
counterparty
(OTC
options)
or
through
a
central
clearinghouse
(exchange-traded
options).
Options
are
included
in
net
assets
at
fair
value,
options
purchased
are
included
in
Investments
in
Securities,
and
options
written
are
separately
reflected
as
a
liability
on
the
accompanying
Statement
of
Assets
and
Liabilities.
Premiums
on
unexercised,
expired
options
are
recorded
as
realized
gains
or
losses
on
the
accompanying
Statement
of
Operations;
premiums
on
exercised
options
are
recorded
as
an
adjustment
to
the
proceeds
from
the
sale
or
cost
of
the
purchase.
The
difference
between
the
premium
and
the
amount
received
or
paid
in
a
closing
transaction
is
also
treated
as
realized
gain
or
loss
on
the
accompanying
Statement
of
Operations.
In
return
for
a
premium
paid,
call
and
put
options
give
the
holder
the
right,
but
not
the
obligation,
to
purchase
or
sell,
respectively,
a
security
at
a
specified
exercise
price. Risks related
to
the
use
of
options
include
possible
illiquidity
of
the
options
markets;
trading
restrictions
imposed
by
an
exchange
or
counterparty;
possible
failure
of
counterparties
to
meet
the
terms
of
the
agreements;
movements
in
the
underlying
asset
values
and,
for
options
written,
the
potential
T.
ROWE
PRICE
Capital
Appreciation
Fund
38
for
losses
to
exceed
any
premium
received
by
the
fund.
During
the
year ended
December
31,
2025,
the
volume
of
the
fund’s
activity
in
options,
based
on
underlying
notional
amounts,
was
generally
between
3%
and
6%
of
net
assets. 
NOTE
4
-
OTHER
INVESTMENT
TRANSACTIONS 
Consistent
with
its
investment
objective, the
fund
engages
in
the
following
practices
to
manage
exposure
to
certain
risks
and/or
to
enhance
performance.
The
investment
objective,
policies,
program,
and
risk
factors
of the
fund
are
described
more
fully
in the
fund’s prospectus
and
Statement
of
Additional
Information.
Noninvestment-Grade
Debt
 The
fund
invests,
either
directly
or
through
its
investment
in
other
T.
Rowe
Price
funds,
in
noninvestment-grade
debt,
including
“high
yield”
or
“junk”
bonds
or
leveraged
loans.
Noninvestment-grade
debt
issuers
are
more
likely
to
suffer
an
adverse
change
in
financial
condition
that
would
result
in
the
inability
to
meet
a
financial
obligation.
The
noninvestment-
grade
debt
market
may
experience
sudden
and
sharp
price
swings
due
to
a
variety
of
factors
that
may
decrease
the
ability
of
issuers
to
make
principal
and
interest
payments
and
adversely
affect
the
liquidity
or
value,
or
both,
of
such
securities.
Accordingly,
securities
issued
by
such
companies
carry
a
higher
risk
of
default
and
should
be
considered
speculative. 
Restricted
Securities
 The
fund
invests
in
securities
that
are
subject
to
legal
or
contractual
restrictions
on
resale.
Prompt
sale
of
such
securities
at
an
acceptable
price
may
be
difficult
and
may
involve
substantial
delays
and
additional
costs.
Bank
Loans
 The
fund
invests
in
bank
loans,
which
represent
an
interest
in
amounts
owed
by
a
borrower
to
a
syndicate
of
lenders.
Bank
loans
are
generally
noninvestment-grade
and
often
involve
borrowers
whose
financial
condition
is
highly
leveraged.
The
fund
may
invest
in
fixed
and
floating
rate
loans,
which
may
include
senior
floating
rate
loans;
secured
and
unsecured
loans,
second
lien
or
more
junior
loans;
and
bridge
loans
or
bridge
facilities.
Certain
bank
loans
may
be
revolvers
which
are
a
form
of
senior
bank
debt,
where
the
borrower
can
draw
down
the
credit
of
the
revolver
when
it
needs
cash
and
repays
the
credit
when
the
borrower
has
excess
cash.
Certain
loans
may
be
“covenant-lite”
loans,
which
means
the
loans
contain
fewer
maintenance
covenants
than
other
loans
(in
some
cases,
none)
and
do
not
include
terms
T.
ROWE
PRICE
Capital
Appreciation
Fund
39
which
allow
the
lender
to
monitor
the
performance
of
the
borrower
and
declare
a
default
if
certain
criteria
are
breached.
As
a
result
of
these
risks,
the
fund’s
exposure
to
losses
may
be
increased.
Bank
loans
may
be
in
the
form
of
either
assignments
or
participations.
A
loan
assignment
transfers
all
legal,
beneficial,
and
economic
rights
to
the
buyer,
and
transfer
typically
requires
consent
of
both
the
borrower
and
agent.
In
contrast,
a
loan
participation
generally
entitles
the
buyer
to
receive
the
cash
flows
from
principal,
interest,
and
any
fee
payments
on
a
portion
of
a
loan;
however,
the
seller
continues
to
hold
legal
title
to
that
portion
of
the
loan.
As
a
result,
the
buyer
of
a
loan
participation
generally
has
no
direct
recourse
against
the
borrower
and
is
exposed
to
credit
risk
of
both
the
borrower
and
seller
of
the
participation.
Bank
loans
often
have
extended
settlement
periods,
generally
may
be
repaid
at
any
time
at
the
option
of
the
borrower,
and
may
require
additional
principal
to
be
funded
at
the
borrowers’
discretion
at
a
later
date
(e.g.
unfunded
commitments
and
revolving
debt
instruments).
Until
settlement,
the
fund
maintains
liquid
assets
sufficient
to
settle
its
unfunded
loan
commitments.
The
fund
reflects
both
the
funded
portion
of
a
bank
loan
as
well
as
its
unfunded
commitment
in
the
Portfolio
of
Investments.
However,
if
a
credit
agreement
provides
no
initial
funding
of
a
tranche,
and
funding
of
the
full
commitment
at
a
future
date(s)
is
at
the
borrower’s
discretion
and
considered
uncertain,
a
loan
is
reflected
in
the
Portfolio
of
Investments
only
if,
and
only
to
the
extent
that,
the
fund
has
actually
settled
a
funding
commitment.
Private
Investments
Issued
by
Special
Purpose
Acquisition
Companies
Special purpose
acquisition
companies
(SPACs)
are
shell
companies
that
have
no
operations
but
are
formed
to
raise
capital
with
the
intention
of
merging
with
or
acquiring
a
company
with
the
proceeds
of
the
SPAC’s
initial
public
offering
(IPO).
The
fund
may
enter
into
a
contingent
commitment
with
a
SPAC
to
purchase
private
investments
in
public
equity
(PIPE)
if
and
when
the
SPAC
completes
its
merger
or
acquisition.
The
fund
maintains
liquid
assets
sufficient
to
settle
its
commitment
to
purchase
the
PIPE.
However,
if
the
commitment
expires,
then
no
shares
are
purchased.
Purchased
PIPE
shares
will
be
restricted
from
trading
until
the
registration
statement
for
the
shares
is
declared
effective.
Upon
registration,
the
shares
can
be
freely
sold;
however,
in
certain
circumstances,
the
issuer
may
have
the
right
to
temporarily
suspend
trading
of
the
shares
in
the
first
year
after
the
merger
or
acquisition.
The
securities
issued
by
a
SPAC
may
be
considered
illiquid,
more
difficult
to
value,
and/or
be
subject
to
restrictions
on
resale.
T.
ROWE
PRICE
Capital
Appreciation
Fund
40
Other 
Purchases
and
sales
of
portfolio
securities
other
than
in-kind
transactions,
if
any, short-term
and
U.S.
government securities
aggregated $51,989,965,000 and
$52,895,026,000,
respectively,
for
the
year ended
December
31,
2025. Purchases
and
sales
of
U.S.
government
securities
aggregated $29,388,251,000 and
$27,740,633,000,
respectively,
for
the
year ended
December
31,
2025.
NOTE
5
-
FEDERAL
INCOME
TAXES
Generally,
no
provision
for
federal
income
taxes
is
required
since
the
fund
intends
to continue
to
qualify
as
a
regulated
investment
company
under
Subchapter
M
of
the
Internal
Revenue
Code
and
distribute
to
shareholders
all
of
its taxable
income
and
gains.
Distributions
determined
in
accordance
with
federal
income
tax
regulations
may
differ
in
amount
or
character
from
net
investment
income
and
realized
gains
for
financial
reporting
purposes.
The
fund
files
U.S.
federal,
state,
and
local
tax
returns
as
required.
The
fund’s
tax
returns
are
subject
to
examination
by
the
relevant
tax
authorities
until
expiration
of
the
applicable
statute
of
limitations,
which
is
generally
three
years
after
the
filing
of
the
tax
return
but
which
can
be
extended
to
six
years
in
certain
circumstances.
Tax
returns
for
open
years
have
incorporated
no
uncertain
tax
positions
that
require
a
provision
for
income
taxes.
Capital
accounts
within
the
financial
reporting
records
are
adjusted
for
permanent
book/tax
differences
to
reflect
tax
character
but
are
not
adjusted
for
temporary
differences.
The
permanent
book/tax
adjustments,
if
any,
have
no
impact
on
results
of
operations
or
net
assets.
The
permanent
book/tax
adjustments
relate
primarily
to
deemed
distributions
on
shareholder
redemptions.
The
tax
character
of
distributions
paid
for
the
periods
presented
was
as
follows:
($000s)
December
31,
2025
December
31,
2024
Ordinary
income
(including
short-term
capital
gains,
if
any)
$
3,061,163‌
$
2,171,176‌
Long-term
capital
gain
2,756,629‌
3,971,739‌
Total
distributions
$
5,817,792‌
$
6,142,915‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
41
At
December
31,
2025,
the
tax-basis
cost
of
investments
(including
derivatives,
if
any)
and
gross
unrealized
appreciation
and
depreciation
were as
follows:
At
December
31,
2025,
the
tax-basis
components
of
accumulated
net
earnings
(loss)
were
as
follows:
Temporary
differences
between
book-basis
and
tax-basis
components
of
total
distributable
earnings
(loss)
arise
when
certain
items
of
income,
gain,
or
loss
are
recognized
in
different
periods
for
financial
statement
purposes
versus
for
tax
purposes;
these
differences
will
reverse
in
a
subsequent
reporting
period.
The
temporary
differences
relate
primarily
to
the
deferral
of
losses
from
wash
sales.
NOTE
6
-
FOREIGN TAXES
The
fund
is
subject
to
foreign
income
taxes
imposed
by
certain
countries
in
which
it
invests.
Additionally,
capital
gains
realized
upon
disposition
of
securities
issued
in
or
by
certain
foreign
countries
are
subject
to
capital
gains
tax
imposed
by
those
countries.
All
taxes
are
computed
in
accordance
with
the
applicable
foreign
tax
law,
and,
to
the
extent
permitted,
capital
losses
are
used
to
offset
capital
gains.
Taxes
attributable
to
income
are
accrued
by
the
fund
as
a
reduction
of
income.
Current
and
deferred
tax
expense
attributable
to
capital
gains
is
reflected
as
a
component
of
realized
or
change
in
unrealized
gain/
loss
on
securities
in
the
accompanying
financial
statements.
To
the
extent
that
the
fund
has
country
specific
capital
loss
carryforwards,
such
carryforwards
are
applied
against
net
unrealized
gains
when
determining
the
deferred
tax
($000s)
Cost
of
investments
$
58,235,052‌
Unrealized
appreciation
$
13,656,928‌
Unrealized
depreciation
(1,017,274‌)
Net
unrealized
appreciation
(depreciation)
$
12,639,654‌
($000s)
Undistributed
ordinary
income
$
118,688‌
Undistributed
long-term
capital
gain
753,314‌
Net
unrealized
appreciation
(depreciation)
12,639,654‌
Total
distributable
earnings
(loss)
$
13,511,656‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
42
liability.
Any
deferred
tax
liability
incurred
by
the
fund
is
included
in
either
Other
liabilities
or
Deferred
tax
liability
on
the
accompanying
Statement
of
Assets
and
Liabilities.
NOTE
7
-
RELATED
PARTY
TRANSACTIONS
The
fund
is
managed
by
T.
Rowe
Price
Associates,
Inc.
(Price
Associates),
a
wholly
owned
subsidiary
of
T.
Rowe
Price
Group,
Inc.
(Price
Group). Price
Associates
has
entered
into
a
sub-advisory
agreement(s)
with
one
or
more
of
its
wholly
owned
subsidiaries,
to
provide
investment
advisory
services
to
the
fund. The
investment
management
agreement
between
the
fund
and
Price
Associates
provides
for
an
annual
investment
management
fee,
which
is
computed
daily
and
paid
monthly.
The
fee
consists
of
an
individual
fund
fee,
equal
to
0.30%
of
the fund’s
average
daily
net
assets,
and
a
group
fee.
The
group
fee
rate
is
calculated
based
on
the
combined
net
assets
of
certain
mutual
funds
sponsored
by
Price
Associates
(the
group)
applied
to
a
graduated
fee
schedule,
with
rates
ranging
from
0.48%
for
the
first
$1
billion
of
assets
to
0.26%
for
assets
in
excess
of
$845
billion.
The
fund’s
group
fee
is
determined
by
applying
the
group
fee
rate
to
the
fund’s
average
daily
net
assets.
At December
31,
2025,
the
effective
annual
group
fee
rate
was
0.28%.
Effective
April
30,
2019,
Price
Associates
has
contractually
agreed,
at
least
through
February
28,
2027,
to
waive
a
portion
of
its
management
fee
so
that
an
individual
fund
fee
of 0.27%
is
applied
to
the
fund’s
average
daily
net
assets
that
are
equal
to
or
greater
than $27.5 billion.
Thereafter,
this
agreement
will
automatically
renew
for
one-year
terms
unless
terminated
by
the
fund’s
Board.
Any
fees
waived
under
this
agreement
are
not
subject
to
reimbursement
to
Price
Associates
by
the
fund. The
total
management
fees
waived
were $12,020,000
and
allocated
ratably
in
the
amounts
of
$6,421,000
for
the
Investor
Class,
$144,000
for
the
Advisor
Class,
and
$5,455,000
for
the
I
Class,
for
the
year
ended
December
31,
2025. 
The
Investor
Class
and
Advisor
Class
are
each
subject
to
a
contractual
expense
limitation
through
the
expense
limitation
dates
indicated
in
the
table
below.
This
agreement
will
continue
through
the
expense
limitation
dates
indicated
in
the
table
below,
and
may
be
renewed,
revised,
or
revoked
only
with
approval
of
the
fund’s
Board.
During
the
limitation
period,
Price
Associates
is required
to
waive
or
pay
any
expenses
(excluding
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage;
non-recurring,
extraordinary
expenses;
and
acquired
fund
fees
and
expenses)
that
would
otherwise
cause
the class’s ratio
of
annualized
total
expenses
to
average
net
assets
(net
expense
ratio)
to
exceed
its
expense
T.
ROWE
PRICE
Capital
Appreciation
Fund
43
limitation.
Each
class
is
required
to
repay
Price
Associates
for
expenses
previously
waived/paid
to
the
extent
the
class’s net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the class’s net
expense
ratio
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
expense
limitation
in
place
at
the
time
such
amounts
were
waived;
or
(2)
the class’s
current
expense
limitation.
However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver.
The
I
Class
is
also
subject
to
an
operating
expense
limitation
(I
Class
Limit)
pursuant
to
which
Price
Associates
is
contractually
required
to
pay
all
operating
expenses
of
the
I
Class,
excluding
management
fees;
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage; non-recurring,
extraordinary expenses; and
acquired
fund
fees
and
expenses, to
the
extent
such
operating
expenses,
on
an
annualized
basis,
exceed
the
I
Class
Limit. This
agreement
will
continue
through
the
expense
limitation
date
indicated
in
the
table
below,
and
may
be
renewed,
revised,
or
revoked
only
with
approval
of
the
fund’s
Board.
The
I
Class
is
required
to
repay
Price
Associates
for
expenses
previously
paid
to
the
extent
the
class’s
net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the
class’s
operating
expenses
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
I
Class
Limit
in
place
at
the
time
such
amounts
were
paid;
or
(2)
the
current
I
Class
Limit.
However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver. 
In
addition,
the
fund
has
entered
into
service
agreements
with
Price
Associates
and
two
wholly
owned
subsidiaries
of
Price
Associates,
each
an
affiliate
of
the
fund
(collectively,
Price).
Price
Associates
provides
certain
accounting
and
administrative
services
to
the
fund.
T.
Rowe
Price
Services,
Inc.
provides
shareholder
and
administrative
services
in
its
capacity
as
the
fund’s
transfer
and
dividend-disbursing
agent.
T.
Rowe
Price
Retirement
Plan
Services,
Inc.
provides
subaccounting
and
recordkeeping
services
for
certain
retirement
accounts
invested
in
the
Investor
Class
and
Advisor
Class.
For
the
year
ended
December
31,
2025,
expenses
incurred
pursuant
to
these
service
agreements
Investor
Class
Advisor
Class
I
Class
Expense
limitation/I
Class
Limit
0.94%
1.19%
0.05%
Expense
limitation
date
02/29/28
02/29/28
02/29/28
(Waived)/repaid
during
the
period
($000s)
$—
$—
$—
T.
ROWE
PRICE
Capital
Appreciation
Fund
44
were
$125,000
for
Price
Associates;
$8,872,000
for
T.
Rowe
Price
Services,
Inc.;
and
$1,028,000
for
T.
Rowe
Price
Retirement
Plan
Services,
Inc.
All
amounts
due
to
and
due
from
Price,
exclusive
of
investment
management
fees
payable,
are
presented
net
on
the
accompanying
Statement
of
Assets
and
Liabilities.
T.
Rowe
Price
Investment
Services,
Inc.
(Investment
Services)
serves
as
distributor
to
the
fund.
Pursuant
to
an
underwriting
agreement,
no
compensation
for
any
distribution
services
provided
is
paid
to
Investment
Services
by
the
fund
(except
for
12b-1
fees
under
a
Board-approved
Rule
12b-1
plan).
The fund
may
invest
its
cash
reserves
in
certain
open-end
management
investment
companies
managed
by
Price
Associates
and
considered
affiliates
of
the
fund:
the
T.
Rowe
Price
Government
Reserve
Fund
or
the
T.
Rowe
Price
Treasury
Reserve
Fund,
organized
as
money
market
funds
(together,
the
Price
Reserve
Funds).
The
Price
Reserve
Funds
are
offered
as
short-term
investment
options
to
mutual
funds,
trusts,
and
other
accounts
managed
by
Price
Associates
or
its
affiliates
and
are
not
available
for
direct
purchase
by
members
of
the
public.
Effective
November
12,
2025, cash
collateral
from
securities
lending,
if
any,
is
invested
in
the
T.
Rowe
Price
Treasury Reserve Fund.
Prior
to
November
12,
2025,
cash
collateral
from
securities
lending,
if
any,
was
invested
in
the
T.
Rowe
Price
Government
Reserve
Fund. The
Price
Reserve
Funds
pay
no
investment
management
fees.
The
fund
may
also
invest
in
certain
other
T.
Rowe
Price
funds
(Price
Funds)
as
a
means
of
gaining
efficient
and
cost-effective
exposure
to
certain
markets.
The
fund
does
not
invest
for
the
purpose
of
exercising
management
or
control;
however,
investments
by
the
fund
may
represent
a
significant
portion
of
an
underlying
Price
Fund’s
net
assets.
Each
underlying
Price
Fund
is
an
open-
end
management
investment
company
managed
by
Price
Associates
and
is
considered
an
affiliate
of
the
fund.
To
ensure
that
the
fund
does
not
incur
duplicate
management
fees
(paid
by
the
underlying
Price
Fund(s)
and
the
fund),
Price
Associates
has
agreed
to
permanently
waive
a
portion
of
its
management
fee
charged
to
the
fund
in
an
amount
sufficient
to
fully
offset
that
portion
of
management
fees
paid
by
each
underlying
Price
Fund
related
to
the
fund’s
T.
ROWE
PRICE
Capital
Appreciation
Fund
45
investment
therein.
Annual
management
fee
rates
and
amounts
waived
related
to
investments
in
the
underlying
Price
Fund(s)
for
the
year
ended
December
31,
2025,
are
as
follows:
Total
management
fee
waived
was
allocated
ratably
in
the
amounts
of
$2,773,000,
$63,000
and
$2,354,000 for
the
Investor
Class,
Advisor
Class
and
I
Class,
respectively,
for
the
year ended
December
31,
2025. 
As
of
December
31,
2025,
T.
Rowe
Price
Group,
Inc.,
or
its
wholly
owned
subsidiaries,
owned
1,058,990
shares
of
the
Investor
Class,
representing
less
than
1%
of
the
Investor
Class's
net
assets,
and
6,416,310
shares
of
the
I
Class,
representing
less
than
1%
of
the
I
Class's
net
assets. 
The fund may
participate
in
securities
purchase
and
sale
transactions
with
other
funds
or
accounts
advised
by
Price
Associates
(cross
trades),
in
accordance
with
procedures
adopted
by the
fund’s
Board
and
Securities
and
Exchange
Commission
rules,
which
require,
among
other
things,
that
such
purchase
and
sale
cross
trades
be
effected
at
the
independent
current
market
price
of
the
security.
During
the
year
ended
December
31,
2025,
the
fund
had
no
purchases
or
sales
cross
trades
with
other
funds
or
accounts
advised
by
Price
Associates.
Price
Associates
has voluntarily
agreed
to
reimburse
the
fund
from
its
own
resources
on
a
monthly
basis
for
the
cost
of
brokerage
commissions
embedded
in
the
cost
of
the
fund’s
foreign
currency
transactions. This
agreement
may
be
rescinded
at
any
time. For
the
year ended
December
31,
2025,
this
reimbursement
amounted
to
$86,000,
which
is
included
in
Net
realized
gain
(loss)
on
Securities
in
the
Statement
of
Operations.
NOTE
8
-
SEGMENT
REPORTING
Operating segments
are
defined
as
components
of
a
company
that
engage
in
business
activities
and
for
which
discrete
financial
information
is
available
and
regularly
reviewed
by
the
chief
operating
decision
maker
(CODM)
in
deciding
how
to
allocate
resources
and
assess
performance.
The
Management
Committee
of
Price
Associates
acts
as
the
fund’s
CODM.
The
fund
makes
($000s)
Effective
Management
Fee
Rate
Management
Fee
Waived
T.
Rowe
Price
Institutional
Floating
Rate
Fund
-
Institutional
Class
0.55%
$
5,190‌
Total
Management
Fee
Waived
$
5,190‌
T.
ROWE
PRICE
Capital
Appreciation
Fund
46
investments
in
accordance
with
its
investment
objective
as
outlined
in
the
Prospectus
and
is
considered
one
reportable
segment
because
the
CODM
allocates
resources
and
assesses
the
operating
results
of
the
fund
on
the
whole.
The
fund’s
revenue
is
derived
from
investments
in
a
portfolio
of
securities.
The
CODM
allocates
resources
and
assesses
performance
based
on
the
operating
results
of
the
fund,
which
is
consistent
with
the
results
presented
in
the
statement
of
operations,
statement
of
changes
in
net
assets
and
financial
highlights.
The
CODM
compares
the
fund’s
performance
to
its
benchmark
index
and
evaluates
the
positioning
of
the
fund
in
relation
to
its
investment
objective.
The
measure
of
segment
assets
is
net
assets
of
the
fund
which
is
disclosed
in
the
statement
of
assets
and
liabilities.
The accounting
policies
of
the
segment
are
the
same
as
those
described
in
the
summary
of
significant
accounting
policies.
The
financial
statements
include
all
details
of
the
segment
assets,
segment
revenue
and
expenses;
and
reflect
the
financial
results
of
the
segment.
NOTE
9
-
OTHER
MATTERS
Unpredictable environmental,
political,
social
and
economic
events,
including
but
not
limited
to,
environmental
or
natural
disasters,
war
and
conflict,
terrorism,
geopolitical
and
regulatory
developments
(including
trading
and
tariff
arrangements),
and
public
health
epidemics
or
threats,
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
a
fund
invests.
The
extent
and
duration
of
such
events
and
resulting
market
disruptions
cannot
be
predicted.
These
and
other
similar
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-
existing
political,
social,
and
economic
risks.
The
fund’s
performance
could
be
negatively
impacted
if
the
value
of
a
portfolio
holding
were
harmed
by
these
or
such
events.
T.
ROWE
PRICE
Capital
Appreciation
Fund
47
REPORT
OF
INDEPENDENT
REGISTERED
PUBLIC
ACCOUNTING
FIRM
To
the
Board
of
Directors
of
T.
Rowe
Price
Capital
Appreciation
Fund,
Inc.
and
Shareholders
of
T.
Rowe
Price
Capital
Appreciation
Fund
Opinion
on
the
Financial
Statements
We
have
audited
the
accompanying
statement
of
assets
and
liabilities,
including
the
portfolio
of
investments,
of
T.
Rowe
Price
Capital
Appreciation
Fund
(one
of
the
funds
constituting
T.
Rowe
Price
Capital
Appreciation
Fund,
Inc.,
referred
to
hereafter
as
the
"Fund")
as
of
December
31,
2025,
the
related
statement
of
operations
for
the
year
ended
December
31,
2025,
the
statement
of
changes
in
net
assets
for
each
of
the
two
years
in
the
period
ended
December
31,
2025,
including
the
related
notes,
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
December
31,
2025
(collectively
referred
to
as
the
“financial
statements”).
In
our
opinion,
the
financial
statements
present
fairly,
in
all
material
respects,
the
financial
position
of
the
Fund
as
of
December
31,
2025,
the
results
of
its
operations
for
the
year
then
ended,
the
changes
in
its
net
assets
for
each
of
the
two
years
in
the
period
ended
December
31,
2025
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
December
31,
2025
in
conformity
with
accounting
principles
generally
accepted
in
the
United
States
of
America.
Basis
for
Opinion
These
financial
statements
are
the
responsibility
of
the
Fund’s
management.
Our
responsibility
is
to
express
an
opinion
on
the
Fund’s
financial
statements
based
on
our
audits.
We
are
a
public
accounting
firm
registered
with
the
Public
Company
Accounting
Oversight
Board
(United
States)
(PCAOB)
and
are
required
to
be
independent
with
respect
to
the
Fund
in
accordance
with
the
U.S.
federal
securities
laws
and
the
applicable
rules
and
regulations
of
the
Securities
and
Exchange
Commission
and
the
PCAOB.
We
conducted
our
audits
of
these
financial
statements
in
accordance
with
the
standards
of
the
PCAOB.
Those
standards
require
that
we
plan
and
perform
the
audit
to
obtain
reasonable
assurance
about
whether
the
financial
statements
are
free
of
material
misstatement,
whether
due
to
error
or
fraud.
T.
ROWE
PRICE
Capital
Appreciation
Fund
48
Our
audits
included
performing
procedures
to
assess
the
risks
of
material
misstatement
of
the
financial
statements,
whether
due
to
error
or
fraud,
and
performing
procedures
that
respond
to
those
risks.
Such
procedures
included
examining,
on
a
test
basis,
evidence
regarding
the
amounts
and
disclosures
in
the
financial
statements.
Our
audits
also
included
evaluating
the
accounting
principles
used
and
significant
estimates
made
by
management,
as
well
as
evaluating
the
overall
presentation
of
the
financial
statements.
Our
procedures
included
confirmation
of
securities
owned
as
of
December
31,
2025
by
correspondence
with
the
custodians,
transfer
agent
and
brokers;
when
replies
were
not
received
from
brokers,
we
performed
other
auditing
procedures.
We
believe
that
our
audits
provide
a
reasonable
basis
for
our
opinion.   
/s/
PricewaterhouseCoopers
LLP
Baltimore,
Maryland
February
18,
2026
We
have
served
as
the
auditor
of
one
or
more
investment
companies
in
the
T.
Rowe
Price
group
of
investment
companies
since
1973.
REPORT
OF
INDEPENDENT
REGISTERED
PUBLIC
ACCOUNTING
FIRM
(continued)
T.
ROWE
PRICE
Capital
Appreciation
Fund
49
TAX
INFORMATION
(UNAUDITED)
FOR
THE
TAX
YEAR
ENDED 12/31/25
We
are
providing
this
information
as
required
by
the
Internal
Revenue
Code.
The
amounts
shown
may
differ
from
those
elsewhere
in
this
report
because
of
differences
between
tax
and
financial
reporting
requirements.
The
fund’s
distributions
to
shareholders
included:
$2,929,731,000
from
long-term
capital
gains,
subject
to
a
long-term
capital
gains
tax
rate
of
not
greater
than
20%
For
nonresident
alien
shareholders,
100%
of
short-term
capital
gain
dividends
distributed
by
the
fund
for
the
fiscal
year
are
qualified
short-term
capital
gains. 
For
taxable
non-corporate
shareholders,
$396,937,000
of
the
fund's
income
represents
qualified
dividend
income
subject
to
a
long-term
capital
gains
tax
rate
of
not
greater
than
20%.
For
corporate
shareholders,
$344,331,000
of
the
fund's
income
qualifies
for
the
dividends-received
deduction.
For
shareholders
subject
to
interest
expense
deduction
limitation
under
Section
163(j),
$1,134,628,000
of
the
fund’s
income
qualifies
as
a
Section
163(j)
interest
dividend
and
can
be
treated
as
interest
income
for
purposes
of
Section
163(j),
subject
to
holding
period
requirements
and
other
limitations.
1307
Point
Street
Baltimore,
Maryland
21231
T.
Rowe
Price
Investment
Services,
Inc.
Call
1-800-638-5660
to
request
a
prospectus
or
summary
prospectus;
each
includes
investment
objectives,
risks,
fees,
expenses,
and
other
information
that
you
should
read
and
consider
carefully
before
investing.
F72-050
2/26


Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies.

Not applicable.

Item 9. Proxy Disclosures for Open-End Management Investment Companies.

Not applicable.

Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.

Remuneration paid to Directors is included in Item 7 of this Form N-CSR.

Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.

If applicable, see Item 7.

Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

 


Item 13. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.

Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.

Item 15. Submission of Matters to a Vote of Security Holders.

There has been no change to the procedures by which shareholders may recommend nominees to the registrant’s board of directors.

Item 16. Controls and Procedures.

(a) The registrant’s principal executive officer and principal financial officer have evaluated the registrant’s disclosure controls and procedures within 90 days of this filing and have concluded that the registrant’s disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSR was recorded, processed, summarized, and reported timely.

(b) The registrant’s principal executive officer and principal financial officer are aware of no change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable.

Item 18. Recovery of Erroneously Awarded Compensation.

Not applicable.

Item 19. Exhibits.

(a)(1) The registrant’s code of ethics pursuant to Item 2 of Form N-CSR is attached.

   (2) Listing standards relating to recovery of erroneously awarded compensation: not applicable.

   (3) Separate certifications by the registrant’s principal executive officer and principal financial officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached.

(b) A certification by the registrant’s principal executive officer and principal financial officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(b) under the Investment Company Act of 1940, is attached.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

T. Rowe Price Capital Appreciation Fund, Inc.
By  

/s/ David Oestreicher

     
  David Oestreicher  
  Principal Executive Officer  
Date    February 18, 2026  

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By  

/s/ David Oestreicher

     
  David Oestreicher  
  Principal Executive Officer  
Date    February 18, 2026  

 

By  

/s/ Alan S. Dupski

     
  Alan S. Dupski  
  Principal Financial Officer  
Date    February 18, 2026  
 

ATTACHMENTS / EXHIBITS

302 CERTIFICATIONS

906 CERTIFICATIONS

CODE OF ETHICS FOR PRINCIPAL EXECUTIVE AND SENIOR FINANCIAL OFFICERS

XBRL TAXONOMY EXTENSION SCHEMA

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: d630021dncsr_htm.xml



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings